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ABSTRACT 
 
GILLIAN SWIFT BACKUS HAZZARD: Susceptibility to ozone-induced pulmonary 
inflammation: investigating the role of the innate immune response 
(Under the direction of Dr. Steven R. Kleeberger) 
 
Exposure to subacute levels of O3 causes decreased lung function, and airway 
hyperresponsiveness in 10-20% of the human population.  Interindividual responses to O3 
vary greatly, which suggests a genetic component.  O3-induced inflammation results from 
activation of the innate immune response via specific receptors such as Toll-like receptor 4 
(TLR4).  TLR4 activation leads to production of soluble mediators such as interleukins (IL)-
12, IL-18, and IL-10 that can affect immune responses.  However, the mechanism underlying 
TLR4-mediated responses as well as the contribution of variants in these specific innate 
immune response mediators have not been investigated in the inflammatory response to O3.  
We hypothesized that specific innate immune response mediators confer differential 
susceptibility to O3-induced inflammation in inbred mice. 
Studies with Tlr4-mutated (C3H/HeJ) and Tlr4-sufficient (C3H/HeOuJ) mice verified a 
role for TLR4 in O3-induced hyperpermeability and neutrophilic responses (Kleeberger et al., 
2000) but the underlying mechanism remains unclear.  The accessory molecule CD14 is 
critical for TLR4-mediated responses to LPS.  However, results from studies using Cd14 
gene-deleted mice were negative and indicated that CD14 is not required for the response to 
O3.  The downstream mediator IL-12 was found to contribute to O3-induced inflammation 
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while IL-18 receptor was protective.  Moreover, O3-induced neutrophilic inflammation was 
dramatically increased in mice lacking IL-10, an important anti-inflammatory cytokine, 
suggesting that IL-10 can potently attenuate neutrophilic influx in response to O3.  Together 
these results suggest that the mechanism underlying O3-induced inflammation occurs 
independently of CD14 and that the cytokine milieu of the lung can alter the severity of 
inflammation in response to O3.  The complex interplay of multiple genetic contributors must 
be considered to gain further insight into how inflammation is regulated in response to O3. 
 iv
ACKNOWLEDGEMENTS 
 
A dissertation is considered a solitary work but along the way, numerous people 
contribute to its successful completion.  I sincerely thank my advisor, Dr. Steven R. 
Kleeberger for his excellent professional mentorship and my committee members Dr. David 
Peden, Dr. Ilona Jaspers, Dr. Scott Randell, and Dr. Donald Cook for their guidance on my 
dissertation project.  NIEHS is a wonderful place to learn how to do research and I am 
indebted to many individuals for their technical expertise including Dr. Carl Bortner, Maria 
Sifre, Dr. Darlene Dixon, Brian Mills, Eric Steele, Louise Fitzgerald, Maureen Puccini, Julie 
Foley and Dr. Bob Maranpot.  Dr. Daniel Morgan, Mr. Herman Price and all the animal 
technicians and engineers at Alion Environmental Science were invaluable in coordinating, 
monitoring, and helping with controlled animal exposures. 
 
I would like to especially thank the members of the Kleeberger lab.  Drs. Hye-Youn Cho, 
Alison Bauer, and Dianne Walters taught me every scientific tool I needed and provided 
constant guidance and editing assistance.  I greatly enjoyed sharing laughter, research 
milestones, frustrations, ideas, and life stories with Laura Miller DeGraff, Jacqui Marzec, 
Wes Gladwell, Christopher Walker, Monica High, Katharine Holder, and Dr. Reuben 
Howden.  They are wonderful friends and talented colleagues. 
 
I am sincerely grateful to my sensational family and friends for their unending support.  
My parents have always encouraged me to follow my dreams; I could not ask for better 
cheerleaders.  I especially thank my grandmother Elizabeth C. Newell, for her wisdom and 
love.  My brother Brad consistently provided gentle and invaluable transatlantic 
encouragement and mentorship.  In their lifetimes, my great aunt Dorothy Barwis, and my 
grandfathers C. Bradford Newell and Richard A. Backus taught me kindness, generosity, the 
value of hard work, and a love of the outdoors.  I also thank my Circle: Shuly, Laurie, Lisa, 
and Christine who provided unconditional friendship and even a quiet place to work during 
the final stages.  And finally, my heartfelt gratitude to my best friend and husband, Thomas 
A. Hazzard, who moved to North Carolina so that I could attend UNC-Chapel Hill.  He has 
faithfully believed in our future; his constant love and support are a blessing.  This work 
represents our collective hopes and dreams. 
 v
TABLE OF CONTENTS 
 
LIST OF TABLES ............................................................................................................ viii 
LIST OF FIGURES ............................................................................................................ ix 
LIST OF ABBREVIATIONS............................................................................................. xi
 
CHAPTER 1: GENERAL INTRODUCTION .................................................................... 1 
Background and Significance .......................................................................................... 2 
Hypothesis and Specific Aims ....................................................................................... 17 
CHAPTER 2: OZONE-INDUCED LUNG HYPERPERMEABILITY AND 
INFLAMMATION ARE INDEPENDENT OF CD14...................................................... 27 
Abstract .......................................................................................................................... 28 
Introduction.................................................................................................................... 29 
Materials and Methods................................................................................................... 31 
Results ............................................................................................................................ 35 
Discussion ...................................................................................................................... 38 
CHAPTER 3: IL-12 AND IL-18 RECEPTOR REGULATE OZONE-INDUCED  
LUNG INFLAMMATION ................................................................................................ 50 
Abstract .......................................................................................................................... 51 
Introduction.................................................................................................................... 53 
Materials and Methods................................................................................................... 55 
Results ............................................................................................................................ 58 
Discussion ...................................................................................................................... 61
 vi
CHAPTER 4: PROTECTIVE ROLE OF IL-10 IN OZONE-INDUCED  
PULMONARY INFLAMMATION .................................................................................. 76 
Abstract .......................................................................................................................... 77 
Introduction.................................................................................................................... 78 
Materials and Methods................................................................................................... 80 
Results ............................................................................................................................ 83 
Discussion ...................................................................................................................... 86 
CHAPTER 5: GENERAL DISCUSSION ......................................................................... 99 
Summary ...................................................................................................................... 100 
Research Implications and Unanswered Questions ..................................................... 103 
Future Directions.......................................................................................................... 114 
Human Implications ..................................................................................................... 117 
Limitations ................................................................................................................... 119 
Conclusion ................................................................................................................... 122 
REFERENCES................................................................................................................. 124 
 
 vii
LIST OF TABLES 
 
Table 1.1:  Distribution of anti-oxidants in the respiratory tract. ........................................... 18 
Table 2.1: cDNA primer sequences and PCR conditions ....................................................... 49 
Table 3.1:  cDNA primer sequences and PCR conditions ...................................................... 67 
Table 3.2:  Effect of targeted disruption of Il18 on BALF inflammatory cells  
and total protein after exposure to filtered air or O3. ...................................................... 68 
Table 4.1:  Effect of targeted deletion of Il10 on the inflammatory response to 
 filtered air and 0.3 ppm O3............................................................................................. 92 
Table 5.1:  Human polymorphisms in innate immune genes and disease associations........ 123 
 
 viii
LIST OF FIGURES 
 
Figure 1.1:  Tropospheric ozone (O3) chemistry. ................................................................... 20 
Figure 1.2:  Ozone (O3) interacts with antioxidants in lung lining tissue and may 
 interact with numerous tissue targets. ............................................................................ 21 
Figure 1.3:  Direct and indirect cellular effects due to O3. ..................................................... 22 
Figure 1.4:  A quantitative trait locus (QTL) for O3-induced hyperpermeability................... 23 
Figure 1.5:  TLR4 mediates pulmonary protein permeability caused by O3. ......................... 24 
Figure 1.6:  Proposed TLR4 signaling pathways in response to O3. ...................................... 25 
Figure 2.1:  Effect of targeted gene disruption of Cd14 on LPS-induced inflammation........ 43 
Figure 2.2:  Effect of targeted gene disruption of Cd14 on O3-induced inflammation. ......... 44 
Figure 2.3:  Effect of targeted gene disruption of Cd14 on TLR4-signaling molecules  
in response to O3. ............................................................................................................ 45 
Figure 2.4:  NF-κB specific DNA binding in response to 0.3 ppm O3 in Cd14+/+ and  
Cd14-/- mice..................................................................................................................... 46 
Figure 2.5:  MIP-2 levels in Cd14+/+ and Cd14-/- mice in response to LPS or O3. ................. 47 
Figure 2.6:  O3-induced proinflammatory gene expression in Cd14+/+ and Cd14
-/- mice....... 48 
Figure 3.1.  Differential mRNA expression of Il12β and Il18 in C3H/HeJ and  
C3H/HeOuJ mice in response to O3................................................................................ 69 
Figure 3.2:  Effect of targeted disruption of Il12 on O3-induced inflammation. .................... 70 
Figure 3.3:  Lung histology in Il12β+/+ and Il12β-/- mice in response to air and O3. .............. 71 
Figure 3.4:  Effect of targeted gene disruption of Il18r1 on O3-induced inflammation. ........ 72 
Figure 3.5:  Lung histology in Il18r1+/+ and Il18r1-/- mice in response to air and O3. ........... 73 
Figure 3.6:  Differential Tnf-α expression in Il18r1+/+ and Il18r1-/- mice in response to  
0.3 ppm O3. ..................................................................................................................... 74 
Figure 3.7:  Differential NF-κβ and AP-1 binding in Il18r1+/+ and Il18r1-/- mice in  
response to air and 0.3 ppm O3. ...................................................................................... 75 
Figure 4.1:  Effect of targeted disruption of Il10 on O3-induced inflammation. .................... 93 
 ix
Figure 4.2:  Lung sections from Il10+/+ and Il10-/- mice exposed to air and O3...................... 94 
Figure 4.3:  IL-10-mediated MIP-2 production in response to O3.......................................... 95 
Figure 4.4:  IL-10 mediated production of CD86 in response to O3....................................... 96 
Figure 4.5:  IL-10 mediated DNA binding by NF-κB in response to O3................................ 97 
Figure 4.6:  STAT-3 activation mediated by IL-10 in response to O3.................................... 98 
 
 x
LIST OF ABBREVIATIONS 
 
AA Ascorbic acid 
AP-1  Activated protein 1 
APC  Antigen presenting cell 
ARE Antioxidant response element 
BALF  Bronchoalveolar lavage fluid 
CD14  Cellular differentiation factor 14 
CD86  Cellular differentiation factor 86 
CO Carbon monoxide 
FEV1 Forced expiratory volume in 1 sec 
FVC Forced vital capacity 
GM-CSF Granulocyte-macrophage colony stimulating factor 
GPx Glutathione peroxidase 
GSH Glutathione 
GSK3-β Glycogen synthase kinase 3-beta 
GST Glutathione S transferase 
H2O2 Hydrogen peroxide 
HBSS Hanks Balanced Salt Solution 
HSPs Heat shock proteins 
ICAM Intercellular adhesion molecule 
ICE IL-1β converting enzyme 
IFN-γ Interferon-gamma 
IL  Interleukin 
 xi
Iκk  Inhibitory kappa kinase 
iNOS Inducible nitric oxide synthase 
IRAK-1  IL-1 receptor associated kinase 1  
IRF-3  Interferon regulatory factor 3 
LOP Lipid ozonation products 
LBP Lipopolysaccharide binding protein 
LPS Lipopolysaccharide 
MD-2 Myeloid differential protein 2 
MHC II Major Histocompatibility Complex II 
MIP-2  Macrophage inflammatory protein 2 
MyD88  Myeloid differentiation factor 88 
NAAQS National ambient air quality standards 
NF-κB  Nuclear factor kappa B 
NOx Nitric oxides 
NQO1 NADP(H): quinone oxidoreductase –1 
Nrf2: Nuclear factor erythroid 2 related factor 2 
O2• Superoxide radical 
O3  Ozone 
•OH Hydroxyl radical 
PAF Platelet activating factor 
PAMPs Pathogen associated molecular patterns 
PGE2 Prostaglandin E2 
PI(3)K Phosphoinositol-3-kinase 
 xii
PM10 Particulate matter: diameter less than 10 μm 
PM2.5 Particulate matter: diameter less than 2.5 μm 
PMN  Polymorphonuclear leukocyte (neutrophil) 
ppm Parts per million 
QTL Quantitative trait locus 
ROO• Peroxyl radical 
ROS Reactive oxygen species 
SOCS-3  Suppressor of cytokine signaling – 3 
SO2 Sulfur dioxide 
STAT-3  Signal transducer and activator of transcription 3 
Th1  T-helper cell, type 1 
Th2  T-helper cell, type 2 
TIR  Toll-IL-1 related protein 
TLR4  Toll-like receptor 4 
TNF-α Tumor necrosis factor alpha 
TRAF-6  Tumor necrosis factor receptor-associated factor 6 
TRAM TRIF-related adapter molecule 
TRIF Toll/IL-1R domain-containing adaptor-inducing IFN-beta 
UA Uric acid 
VOCs Volatile organic compounds 
 
 xiii
CHAPTER 1: GENERAL INTRODUCTION 
 
Background and Significance 
Air pollution is a global concern.  Beginning in the mid-20th century, industrialized 
nations began to notice decreases in air quality that correlated with adverse health effects.  In 
two independent episodes, stagnant pollution-filled airmasses in two industrial cities Liege, 
Belgium (1930) and Donora, Pennsylvania, USA (1948) contributed to elevated morbidity 
and mortality rates (Bell and Davis, 2001; Nemery et al., 2001).  From December 5-9, 1952 a 
thick, toxic smog reduced visibility to several feet and caused an estimated excess 12,000 
deaths in London, England (Bell and Davis, 2001).  This third event catapulted air pollution 
into the realm of public health and heightened the search for mechanisms by which polluted 
air might be linked with specific adverse health endpoints, including death.  In the past 50 
years, researchers have provided extensive evidence that acute exposures not only cause 
visible and immediate health effects such as reduced lung function and increased airway 
hyperresponsiveness but also are correlated with chronic health problems such as chronic 
cardiopulmonary disease, emphysema, and asthma (Pope, 2000).  Subpopulations including 
children and the elderly are particularly susceptible to increased morbidity and mortality 
following acute exposures of air pollution (Pope, 2000). 
Air pollution is a heterogeneous mixture of particles, and photochemical by-products such 
as ground level ozone (O3).  Epidemiological, clinical and basic research evidence has 
determined toxic effects of air pollution components in respiratory airways and prompted 
regulatory action.  In 1970, the Clean Air Act gave the Environmental Protection Agency 
power to regulate six criteria air pollutants including nitric oxides (NOx), sulfur dioxide 
(SO2), particulate matter (PM10 and PM2.5), lead, carbon monoxide (CO) and O3.  The current 
(1997) National Ambient Air Quality Standard (NAAQS) for O3 is an 8 hr standard. The 8-hr 
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standards are met when the three-year average of the annual fourth highest daily maximum 8-
hr average concentration is less than 0.08 parts per million (ppm). 
Despite governmental regulation in this and other countries, photochemical pollution 
continues to be a major public health concern.  As of 2004, 124 U.S. cities routinely had O3 
levels that exceeded the NAAQS.  Air Pollution and Health: a European Approach (APHEA) 
found that increases of 50 μg/m3 of O3 (1 hr max) was correlated with a 2.9% increase in 
total mortality across 6 European cities in 1997 (Touloumi et al., 1997).  Air quality issues 
are evident on nearly every continent.  Los Angeles, Mexico City, Buenos Aires, and Beijing 
are among the most polluted cities in the world for O3 
(http://www.sbg.ac.at/ipk/avstudio/pierofun/mexico/air.htm, 06-08-2006).  Moreover, there is 
increasing evidence of intercontinental pollution transport from Central America and Asia to 
the U.S., as well as transboundary air pollution from Mexico to the U.S. and between the U.S 
and Canada.  Intercontinental air quality issues are just beginning to be addressed 
(http://www.epa.gov/airtrends/international.html, 06-14-06).  Effectively solving air 
pollution problems, including those caused by O3, requires continued scientific research as 
well as political initiatives, economic incentives, public health awareness, and global 
cooperation. 
 
The biochemistry of tropospheric O3  
Since O3 was first identified as a prevalent component of photochemical smog in the Los 
Angeles, CA basin in the 1940’s, it has been known as the most active and toxic gaseous 
pollutant in the breathable atmosphere of many large cities in industrialized countries, 
especially during hot summer months.  Ground level O3 forms largely as a secondary 
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byproduct of photochemical reactions with nitrous oxides (NOx) and volatile organic 
compounds (VOCs) (Figure 1.1A).  NOx and VOCs are generated from commercial/industrial 
and natural sources such as motor vehicles, aircraft, power stations, forest fires, trees and 
vegetation.  NOx and VOCs react with singlet oxygen (1ΔgO2) and molecular oxygen (O2) in 
the presence of ultraviolet (UV) light, particularly on hot, stagnant summer days.  As a 
powerful oxidant, environmental O3 leads to cyclical and self-generating oxidative reactions.  
When VOCs and NOx react with normally harmless air components such as H2O and O2 in 
the presence of UV light, highly unstable radical and non-radical reactive oxygen species 
(ROS) including superoxide (O2·), hydrogen peroxide (H2O2), the hydroxyl radical (·OH), 
and O3 are formed (Figure 1.1B). 
Because O3 is highly reactive, it likely does not penetrate cells.  Instead, the unstable O3 
molecule reacts further with various electrophiles to form more ROS such as the hydroxyl 
radical (·OH) and peroxyl radical (ROO·), which attack electron-containing biomolecules 
including proteins (e.g. prostaglandin synthase and elastase), lipids (e.g. lipid peroxidation 
chain reactions) and nucleic acids (e.g. DNA damage).  O3 can react directly with membrane 
lipids and lung lining fluid lipids to form lipid ozonation products (LOPs) including 
aldehydes and hydroxyhydroperoxides.  LOPs induce release of proinflammatory mediators 
and injury-associated markers from damaged tissue that may trigger further cellular damage 
(Bulut et al., 2002; Gupta et al., 1998; Okamura et al., 2001; Wong et al., 1996). 
Antioxidants are distributed throughout the airways in both extracellular and cellular 
compartments and have scavenger and enzymatic activities (Table 1).  Inhaled oxidants 
interact initially with antioxidants such as glutathione, ascorbic acid and uric acid located in 
the epithelial lining fluid.  When the oxidant burden exceeds the capacity of these 
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antioxidants, inducible secondary antioxidant enzymes (e.g. glutathione peroxidase, 
superoxide dismutases (SOD)) participate in antioxidant defense (Mudway and Kelly, 2000) 
(Figure 1.2).  Phase 2 detoxifying enzymes (e.g. glutathione-S-transferase isozymes (GST), 
NADP (H): quinone oxidoreductase (NQO1)) assist these proteins and small molecules by 
facilitating elimination or detoxification of oxidized biomolecules.  The expression of these 
antioxidant proteins is controlled by redox-sensitive transcription factors (e.g. activator 
protein (AP)-1, nuclear factor (NF)-κB, and nuclear factor erythroid 2 (NF-E2) related factor 
2 (Nrf2)). 
Antioxidant defenses can be overwhelmed by high doses of oxidants, increased ventilation 
during exercise, or decreased antioxidant production and lead to oxidative stress.  Individuals 
most at risk for oxidant injury include those with lower amounts or differential distribution of 
antioxidants, either by genetics or through preexisting disease (Mudway and Kelly, 2000).  In 
mouse studies, antioxidant levels have been associated with differential susceptibility to O3 
(Johnston et al., 2000) (Jang et al., 2005).  In asthmatic children, polymorphisms in the gene 
encoding GST (GSTM1) were correlated with increased susceptibility to O3-induced 
decrements in respiratory flow (Romieu et al., 2004). 
 
Adverse health effects of O3
That O3 and other components of air pollution have been associated with increased 
morbidity and mortality emphasizes the critical negative effects of these pollutants on the 
lung (Kleeberger, 2005).  Experimental and epidemiological studies have associated O3 with 
decrements in pulmonary function (FEV1, FVC and increased airway resistance) (Hazucha et 
al., 1989), increased airway hyperresponsiveness (Mudway and Kelly, 2000), pulmonary 
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inflammation (Driscoll et al., 1993), hyperpermeability (Longphre et al., 1999), epithelial cell 
damage and proliferation (Johnston et al., 2002), and immune system effects (Jakab et al., 
1995).  For a given exposure to O3, interindividual variation in the magnitude of the 
pulmonary response suggests an intrinsic factor(s) that confer(s), susceptibility.  This is cause 
for concern particularly in patients whose airways are already compromised by obstructive 
pulmonary disease or sensitized by allergens and may therefore be at risk for exacerbated 
injury in the presence of O3 (Mudway and Kelly, 2000).  Epidemiology studies support an 
association between O3 exposure and aggravated asthmatic symptoms (Bayram et al., 2001; 
Gilliland et al., 2001) and increased incidence of asthma (McConnell et al., 2002). 
Airway inflammation is the predominant toxicity caused by O3 in humans as well as 
multiple animal models (Bascom, 1996).  In response to O3, activated airway cells release 
inflammatory mediators including tumor necrosis factor alpha (TNF-α)  (Cho et al., 2001), 
macrophage inflammatory protein 2 (MIP-2) (Driscoll et al., 1993; Johnston et al., 1999), 
platelet activating factor (PAF) (Longphre et al., 1999), Interleukin (IL-) 8, and IL-6 (Devlin 
et al., 1994).  These mediators contribute to the hallmark phenotypes of O3-induced 
inflammation – neutrophilic infiltration and hyperpermeability (Figure 1.3).  In addition, the 
hyperpermeability response correlates with inducible nitric oxide synthase (iNOS) mRNA 
levels (Kleeberger et al., 2001).  O3-damaged cells also release mediators such as heat shock 
proteins (HSPs) and fibronectin.  Fibronectin has been detected in response to O3 in cultured 
airway cells (Devlin et al., 1994) and in rodent airways (Gupta et al., 1998).  HSPs have also 
been associated with O3 exposure in rat (Wong et al., 1996) and guinea pig models (Su and 
Gordon, 1997).  Fibronectin (Okamura et al., 2001) and HSPs (Bulut et al., 2002; Vabulas et 
al., 2001) are putative ligands of Toll-like receptor 4, an innate immune receptor responsible 
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for inflammatory mediator production.  The interaction between HSPs and fibronectin and 
specific innate immune receptors provide a possible indirect mechanism of O3-induced 
inflammation.   
Exposure to subacute doses of O3 causes decreased lung function and airway 
hyperresponsiveness in 10-20% of the human population (Mudway and Kelly, 2000).  These 
effects are determined in part by environmental factors such as duration, frequency and 
concentration of exposure, and other extrinsic factors such as socioeconomic factors and pre-
exposures to other airway irritants and toxics, in combination with various intrinsic factors 
such as genetics, gender, health status, age, and diet (Balmes et al., 1996; Kleeberger, 2005).  
The genetic mechanism underlying differential susceptibility to O3 has been studied for the 
past decade using murine models.  This dissertation project investigated underlying genetic 
susceptibility to O3-induced pulmonary inflammation by focusing on the role of specific 
innate immune genes that control the inflammatory response in mice. 
 
O3 and the Pulmonary Immune Response 
The lung is primarily considered a gas exchange organ.  Because the lung is continuously 
exposed to mixtures of antigens, toxicants and oxidants present in ambient air, it also must be 
immunologically active (Strieter et al., 2002).  Moreover, the pulmonary immune response 
must be carefully regulated in order to preserve the integrity of the fragile, highly 
vascularized epithelial surfaces in the organ, particularly those at which gas exchange occurs 
(Holt, 2000). 
Oxidative damage due to O3 exposure is limited by numerous anti-oxidant molecules and 
enzymes present in the upper and lower respiratory tract.  However, when anti-oxidant 
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defenses are overwhelmed, oxidative damage and subsequent injury and inflammation occur.  
O3 has been known to alter macrophage function and immunologic competence in the lung 
(Gilmour et al., 1993).  In the lung parenchyma, alveolar macrophages and other antigen 
presenting cells (APCs) are the first line of immune defense and are accompanied by 
neutrophilic (PMN) infiltration (Mudway and Kelly, 2000) as well as injury markers (e.g. 
HSPs, fibronectin, nitric oxide) that can heighten an immune response and cause further 
damage.  Activated APCs produce cytokines that propagate the inflammatory response and 
simultaneously activate the adaptive immune response by driving differentiation of T-cells 
into one of two mutually exclusive subsets: Th1 or Th2.  Other factors including arachidonic 
acid metabolites, coagulation factors, complement, acute-phase proteins, and antimicrobial 
peptides are also involved in the innate immune response, but cytokines are by far the largest 
and most pleiotropic of the innate immune mediators.  Moreover, cytokines contribute to all 
phases of the innate immune response – initiation, maintenance, and resolution (Strieter et 
al., 2002). 
Successful innate defense responses in the lung lead to the eventual transition and 
development of adaptive immunity (Strieter et al., 2002).  In addition to antigen presentation, 
macrophages and other APCs upregulate co-stimulatory molecules such as CD86.  CD86 
interacts with CD28 on T-cells.  In the absence of co-stimulation, T-cells are primed but not 
activated (anergic). Moreover, APCs produce cellular mediators that act in paracrine or 
autocrine fashion to alter the cytokine milieu.  IL-12 and IL-18 are two such mediators 
produced by innate immune cells and have been shown to control Th1 production.  IL-10 is a 
potent anti-inflammatory cytokine produced by macrophages, T-cells and B-cells.  IL-10 can 
inhibit inflammation by acting either on macrophages or on T-cells, and thus has dual 
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functions in modulating both innate and adaptive immune responses.  The interplay between 
the adaptive and innate arms of the immune system is critical for proper immune function but 
is not well understood, particularly in response to O3. 
There are several lines of evidence to suggest that O3 can modulate the adaptive immune 
response.  Epidemiology studies have shown that O3 exposure can exacerbate allergic 
responses in humans (Kunzli et al., 2003; McConnell et al., 2002).  Studies in animal models 
have confirmed that when antigenic stimulation occurs during O3 exposure, allergic 
responses are enhanced (Holz et al., 2002; Jakab et al., 1995).  Taken together, these studies 
provide indirect evidence that O3 may influence immune responsiveness by “priming” the 
adaptive response. 
Studies to assess the effect of O3 on T-cells suggest immunosuppressive and 
immunoactivating functions.  Holz et. al. (2001) reported that the numbers of CD4+ 
lymphocytes increase as do proportions of T-helper cells after single exposures to 0.2 ppm 
O3 in normal human subjects (Holz et al., 2001).  In cell culture, however, nonspecific clonal 
expansion of T cells was inhibited by direct exposure to 0.1 to 1.0 ppm O3 (Becker et al., 
1989).  Koike et. al. (1998) found that, in response to a 3-day exposure of 1.0 ppm O3, 
suppression of lymphocyte proliferation by alveolar macrophages could be inhibited by the 
O3-induced release of soluble factors that inhibit nitric oxide (Koike et al., 1998).  When T-
cell function was suppressed by cyclosporine A in mice, O3-induced lesions were greater 
than O3 alone and implicate a role for T-cells in suppressing the response to 0.7 ppm O3 
(Bleavins et al., 1995).  In another T-cell depletion study using an anti-Thy1.2 antibody, the 
numbers of inflammatory cells in the bronchoalveolar lavage fluid (BALF) significantly 
decreased after 0.3 ppm O3 compared to untreated mice (Chen et al., 1995) and suggest that 
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T-cells actively participate in the inflammatory response.  While an immunomodulatory 
effect has been implicated in response to O3, different dose regimens and different measured 
endpoints make it difficult to compare studies and assess human risk.  In addition, different 
T-cell subsets may have distinct functions – some attenuate the immune response (T 
regulatory cells) while others promote enhanced responses (T helper cells).  Further research 
is required to uncover the underlying mechanism for the observed immunomodulatory 
effects. 
 
Influence of innate immune response genes on pulmonary susceptibility to O3
Significant interindividual differences to O3 sensitivity suggest a genetic component that 
has been investigated in mouse models and humans (Goldstein et al., 1973; Kleeberger et al., 
1993b; Kleeberger et al., 1997).  Kleeberger et. al. (1997, 2000) used segregant populations 
of differentially susceptible mice to study the genetics of O3-induced pulmonary neutrophilic 
inflammation and hyperpermeability (Kleeberger et al., 1997; Kleeberger et al., 2000).  
Using linkage analysis, Kleeberger et. al. (2000) identified a significant quantitative trait 
locus (QTL) for susceptibility to O3-induced hyperpermeability on murine chromosome 4 
(Figure 1.4) (Kleeberger et al., 2000).  This locus contains the candidate gene, toll-like 
receptor 4 (Tlr4).  Originally discovered in Drosophila melanogaster, the highly conserved 
TLRs belong to the IL-1 superfamily of innate immune receptors.  Studies using Tlr4-mutant 
(C3H/HeJ) and Tlr4-normal (C3H/HeOuJ) strains of mice verified a role for TLR4 in O3-
induced hyperpermeability (Figure 1.5) (Kleeberger et al., 2000).  Initial research showed 
that TLR4 altered O3-induced hyperpermeability via inducible nitric oxide synthase (iNOS) 
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(Kleeberger et al., 2001).  However, further mechanistic studies are needed to determine 
detailed mechanisms underlying Tlr4-mediated pulmonary O3 toxicity. 
 
TLR4 structure and function 
TLRs are essential mediators of host defense by recognition of pathogen associated 
molecular patterns (PAMPs) (Qureshi et al., 2006).  Of the 11 mammalian TLRs, only TLR4 
recognizes the non-variant Lipid A component of lipopolysaccharide (LPS), a surface 
glycolipid of most gram-negative bacteria.  To transduce an LPS signal, the lipid A moiety 
binds to lipopolysaccharide binding protein (LBP) that interacts with CD14 and MD2, two 
TLR-associated receptors (Kurt-Jones et al., 2000).  These accessory cell-surface molecules 
cannot initiate signaling due to the lack of transmembrane domains.  In LPS responsiveness, 
the bound ligand complex is required for dimerization with TLR4 and subsequent initiation 
of downstream signaling.  In the absence of Cd14, response to LPS is severely attenuated in 
mice (Haziot et al., 1996).  However, the role of CD14 in O3-induced pulmonary injury and 
inflammation has not been investigated. 
TLR4-mediated signaling occurs via myeloid differentiation factor 88 (MyD88)-
dependent and -independent pathways (Figure 1.6).  The MyD88 pathway requires the 
adaptor molecules TNF receptor associated factor (TRAF)-6 and IL-1 receptor associated 
kinase (IRAK)-1 to lead to nuclear translocation of nuclear factor kappa B (NF-κB), a 
transcription factor commonly implicated in upregulation of pro-inflammatory gene 
expression.  The MyD88-independent pathway utilizes the Toll/IL-1R domain-containing 
adaptor-inducing Interferon-β (TRIF) and TRIF-related adaptor molecule (TRAM) adaptor 
molecules and leads to interferon regulatory factor (IRF)-3 activation.  TLR4 activation 
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results in upregulation of important pro-inflammatory cytokines such as TNF-α and 
macrophage inflammatory protein (MIP)-2.  Independently, studies have shown that TNF-α 
and TNF receptor contribute to O3-induced inflammation in rodents (Bhalla et al., 2002; Cho 
et al., 2001).  MIP-2 also increases in response to O3 in rats (Bhalla and Gupta, 2000).  LPS 
can induce IL-12 and IL-18 expression in vitro via the c-Rel subunit of NF-κΒ (Mason et al., 
2002; Sanjabi et al., 2000), which suggests a role for TLR4 in the expression of these 
regulatory cytokines.  TLR4 also controls inflammation by induction of anti-inflammatory 
cytokines such as IL-10 (Higgins et al., 2003). 
 
IL-12 Structure and Function 
IL-12 is a heterodimeric protein (70 kD) consisting of p35 (IL-12α) and p40 (IL-12β) 
subunits (Gately et al., 1998; Trinchieri, 2003).  IL-12, produced by B-cells and 
macrophages, promotes Th1 responses, and suppresses Th2 responses by stimulating naïve T 
cells to differentiate into interferon gamma (IFN-γ) secreting T-cells (Gately et al., 1998).  
Murine Il12α shares 75% sequence homology with human IL12A.  It is located on 
chromosome 3 in both species while the murine Il12β gene is located on chromosome 11 and 
shares 82% sequence homology with human IL12B on chromosome 5.  Polymorphisms in 
IL12B and concomitant altered IL-12β structure and function have been associated with 
autoimmune diabetes in non-obese diabetic (NOD) mice (Adorini, 2001), hepatitis C virus 
infectivity (Houldsworth et al., 2005), and atopic asthma (Hirota et al., 2005; Morahan et al., 
2002; Randolph et al., 2004).  Single nucleotide polymorphisms in human IL12A and five 
other genes have been associated with a significant decrease in total white blood cell counts 
in response to occupational benzene exposure but has not been confirmed using gene-
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targeted animal models to mimic this phenotype (Lan et al., 2005).  The polymorphism data 
suggests that of the two IL-12 subunits, the IL-12β (p40) subunit may be more important in 
terms of modulating inflammatory disease than IL-12α (p35). 
IL-12 is produced by LPS-stimulated macrophages, suggesting a role for TLR4 
(Trinchieri, 2003) as well as activated B-cells.  A TLR4 polymorphism (Asp299Gly) 
associated with asthma was also implicated in reduced LPS-induced production of IL-12p70 
in Swedish children (Fageras Bottcher et al., 2004).  TLR4-dependent IL-12α production 
appears to occur via MyD88-independent pathways (Goriely et al., 2006).  However, the 
contribution of IL-12 in the pulmonary pathogenesis of O3-induced injury and inflammation 
has not been determined. 
 
IL-18 Structure and Function 
IL-18, initially called IFN-γ inducing factor, is an 18 kD single polypeptide that shares 
structural homology with IL-1 (Okamura et al., 1995).  It is derived from the enzymatic 
cleavage of a 23kD precursor by IL-1β converting enzyme (ICE) that is activated by LPS 
(Schumann et al., 1998).  IL-18 is expressed in macrophages, T-cells, B-cells and airway 
epithelium (Cameron et al., 1999).  The gene encoding IL-18 is located on chromosome 1 
(humans) and chromosome 9 (mice), and is 75% homologous.  IL-18 is involved in 
production of pro-inflammatory mediators including IL-8, TNF-α and intercellular adhesion 
molecule (ICAM)-1. 
IL-18 has been associated with a number of inflammatory diseases including rheumatoid 
arthritis (Liew, 2001), LPS-induced liver injury (Sakao et al., 1999), and asthma (Wild et al., 
2000).  IL-18 overexpression in the skin aggravated allergic cutaneous inflammation and was 
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accompanied by high expression of Th1 and Th2 cytokines (Kawase et al., 2003).  Low 
levels of IL-18 have been associated with asthma and sarcoidosis (Ho et al., 2002).  Elevated 
circulating levels of IL-18 have been correlated with HIV-1 seroconversion.  Significant 
associations have been found between polymorphisms in IL18 and asthma (105:G/C) (Higa 
et al., 2003), allergic rhinitis (-607, promoter) (Lee et al., 2006), atopic eczema (+113:G/C, 
+127:G/C, -137:G/C, -133:G/C) (Novak et al., 2005), mite allergens (-148:G/C)(Shin et al., 
2005), and latex allergy (-656, promoter) (Brown et al., 2005).  Taken together, these studies 
suggest that IL-18 has pro-inflammatory functions and can critically modulate inflammation 
in response to infection, autoimmune disease, and allergic responses. 
IL-18 production increases in response to LPS (Joshi et al., 2002; Rouabhia et al., 2002) 
and IL-18 neutralizing antibodies decrease LPS-induced myocardial dysfunction (Raeburn et 
al., 2002), suggesting a role for TLR4 in IL-18 production.  This effect may depend on prior 
immune status, however.  Sakao et. al. (1999) found that Il18 deficient mice primed with a 
low dose (200 μg) of heat-killed Propionbacterium acnes were resistant to LPS-induced liver 
injury but were highly susceptible when injected with a high dose (1 mg) of heat-killed P. 
acnes prior to LPS challenge (LPS-induced endotoxin shock) (Sakao et al., 1999).  
Moreover, few studies have used a Tlr4-deficient mouse model to directly correlate IL-18 
production with TLR4.  IL-18 may work in an autofeedback loop to control TLR4 levels or 
activation.  Radstake et. al. (2004) determined by flow cytometry that IL-18 together with 
IL-12 can activate IFN-γ-mediated Tlr2 and Tlr4 expression in rheumatoid arthritis patients 
though the mechanism of this effect remains unknown(Radstake et al., 2004). 
The heterodimeric IL-18 receptor (IL-18R1) is a 62 kD protein that specifically binds IL-
18, and is expressed on macrophages as well as naïve and activated T- and B-cells.  It is 
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composed of a ligand binding subunit (IL1Rrp or IL-18Rβ) and a signal transducing unit (IL-
18acPL or IL-18Rα) (Sergi and Penttila, 2004).  IL-18R1 shares structural homology with 
receptors of the IL-1 superfamily including IL-1R and TLR4.  The human IL18 Receptor 1 
gene (IL18R1) shares 75% homology with the murine form, and is located on chromosome 2 
along with a cluster of IL-1 related genes.  IL18R1 promoter polymorphisms have recently 
been identified at –69 and –638 (Cardoso et al., 2004) but functional relevance to human 
disease has not yet been established.  The IL-18R-α subunit leads to transcriptional 
activation of NF-κΒ through the MyD88, IRAK-1, and TRAF-6 pathway and suggests that 
IL-18R1 shares a common pathway with TLR4.  Its structural homology to other innate 
immune receptors and its ability to activate a common pro-inflammatory pathway suggest 
that IL-18R1 may contribute to O3-induced inflammation. 
Taken together, the pro-inflammatory activities of IL-12, IL-18, and IL-18R1 have been 
well documented.  IL-12 may be a downstream effector of TLR4, while IL-18R1 shares 
structural homology to TLR4 and a common signaling pathway leading to inflammatory 
cytokine expression.  Moreover, functional polymorphisms in IL12B, and IL18 have been 
correlated with differential responses in a variety of inflammatory disorders and may serve as 
important genetic markers for susceptibility to pulmonary inflammatory diseases. 
 
IL-10 Structure and Function 
IL-10 is a homodimeric protein product of Il10 that is located on human and murine 
chromosome 1 (Kim et al., 1992).  Human and murine genes share 81% sequence homology.  
IL-10 is a pleiotropic immunoregulatory and anti-inflammatory cytokine produced by 
activated monocytes, helper T cells, and B cells, amongst others.  IL-10 attenuates 
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inflammation by inhibiting pro-inflammatory cytokines and chemokines (Lang et al., 2002; 
Standiford et al., 1995), cell injury markers (Cunha et al., 1992; Tulic et al., 2001), and 
activation of pro-inflammatory transcription factors  (Saadane et al., 2005).  IL-10 also 
affects the adaptive immune response by downregulating T-cell activation via decreased 
macrophage CD86 expression (Ding et al., 1993) and inhibition of CD28 tyrosine 
phosphorylation (Akdis et al., 2000) leading to anergic adaptive immune cells (Flores 
Villanueva et al., 1994). 
A number of models suggest, indirectly and directly, an association between TLR4 and 
IL-10.  LPS-induced lethality in mice increased significantly when endogenous IL-10 
bioactivity was neutralized (Standiford et al., 1995).  Similarly, intranasally administered 
recombinant murine IL-10 reduced lung inflammation and bronchopulmonary 
hyperreactivity caused by LPS exposure (Deleuze et al., 2004).  In an LPS-challenged murine 
model of cystic fibrosis, recombinant IL-10 attenuated excessive inflammation (Saadane et 
al., 2005).  In addition, TLR4-mediated IL-10 production has been shown to confer 
resistance to Bordetella pertussis, a gram-negative bacteria, by inhibiting inflammatory 
pathology (Higgins et al., 2003). 
IL-10 secretion from LPS-stimulated blood cultures varied greatly and led to structural 
analysis of the human IL10 gene to positively identify functional promoter polymorphisms 
(Eskdale et al., 1998a; Eskdale et al., 1998b).  IL10 polymorphisms have been associated 
with inflammatory disorders including sudden infant death due to infection (-592:A/C) 
(Summers et al., 2000), and rheumatoid arthritis (-2849:A/G) (Lard et al., 2003). 
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Hypothesis and Specific Aims 
Exposure to environmental O3 has been shown to induce pulmonary inflammation, and 
cause altered immune responses particularly in susceptible individuals (Jakab et al., 1996; 
Kleeberger, 1995; Mudway and Kelly, 2000).  The underlying genetic contributions to these 
responses are not well understood.  Although previous studies demonstrated the role of TLR4 
in the pathogenesis of O3-induced pulmonary injury, details of molecular mechanisms 
underlying TLR4-mediated responsiveness and the role of TLR4-inducible cytokines are 
unclear.  We hypothesized that differential response to O3 may be regulated by innate 
immune genes at the receptor level (Cd14) and downstream of TLR4 (Il12α, Il12β, Il18, 
Il18r1, Il10).  Our specific aims were: 1) to characterize the role of the Toll-like receptor 4 
accessory molecule CD14 in modulating receptor level events to the response to O3; 2) to 
assess the downstream effector-level contribution of IL-12 and IL-18 to O3-induced 
inflammation and; 3) to elucidate the putative anti-inflammatory role of IL-10 in a subacute 
O3 model.  We utilized mice genetically deficient in Cd14, Il12α, Il12β, Il18, Il18r1, and 
Il10 to assess whether these genes specifically contribute to O3-induced pulmonary 
pathogenesis. 
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Table 1.1:  Distribution of anti-oxidants in the respiratory tract. 
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Name Location Reactant Mechanism 
Uric Acid Lung lining fluid, 
upper airways 
Hydroxyl radical Scavenger 
α-tocopherol Lung lining fluid, 
distal airways 
Peroxyl radical  Scavenger, chain 
breaking, 
terminates lipid 
peroxidation, 
Glutathione (GSH) Ubiquitous: Lung 
lining fluid, distal 
airways 
H2O2 Thiol for oxidant-
antioxidant 
equilibrium 
Ascorbic Acid Lung lining fluid, 
distal airways 
Superoxide, 
peroxyl, H2O2, 
singlet O 
Scavenger 
Glutathione 
peroxidase (GSH-
Px) 
Lung lining fluid and 
cellular, lavage cells, 
Epithelial cells, 
macrophages 
Organic 
hydroperoxides, 
including H2O2
Enzyme 
Superoxide 
dismutase (SOD) 
Lung lining fluid, 
produced by epithelial 
cells (EC-SOD), type 
II alveolar cells, 
macrophages, 
neutrophils 
O2· Enzyme 
Catalase  Ubiquitous: Lung 
lining fluid, 
macrophages, 
fibroblasts, type II 
pneumocytes  
H2O2 Enzyme 
NADP(H):quinone 
oxidoreductase 
(NQO1) 
Intracellular Quinones Phase II 
detoxifying 
enzyme  
Glutathione-S-
transferase (GST) 
Intracellular Quinones, 
aldehydes, 
epoxides, H2O2
Phase II 
detoxifying 
enzyme 
 
Antioxidants vary in their distribution, substrate (reactant) and mode of action 
(mechanism). 
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 Figure 1.1:  Tropospheric ozone (O3) chemistry. 
 
(A) O3 forms in the troposphere when nitric oxides (NOx) and volatile organic 
compounds (VOCs), formed from combustion reactions react with molecular O2 in the 
presence of ultraviolet light (UV) to form byproducts such as the hydroxyl radical (•OH), 
hydrogen peroxide (H2O2) and O3.  (B) NO2 and O2 can produce nitrogen radicals (NO•) 
as well as O3.  Singlet oxygen (O•), formed from light-catalyzed degradation of NO2, can 
react with molecular O2 to form O3.  O3 can react with NO
. to regenerate NO2 and O2.  
Thus, O3 formation reactions are cyclical. 
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Figure 1.2:  Ozone (O3) interacts with antioxidants in lung lining tissue and may interact 
with numerous tissue targets. 
 
Water-soluble glutathione (GSH), ascorbic acid (AA), and uric acid (UA) are present in 
the lung lining fluid and are thought to interact directly with O3. When antioxidant 
defenses are insufficient, O3 reacts with proteins and lipids to potentially inactivate 
enzymes and form lipid ozonation products (LOPs), respectively.  Secondary antioxidants 
such as α-tocopherol (α-toc) and glutathione peroxidase (GPx) counteract lipid 
autooxidation products and extracellular superoxide dismutase (EC SOD) removes 
superoxide formed as a by-product.  O3 promotes neutrophilic infiltration.  Neutrophils 
(Neut) produce their own toxic reactive oxygen species (ROS) and contribute to the total 
lung oxidant burden.  Lymphocytes (Lymp), mast cells, alveolar macrophages (A.M.), 
Ciliated Epithelial Cells (C.E.C.), and Type I Cells (T.I.C.) are all affected by exposure to 
ROS.  Other abbreviations: Epi, epithelium; Inst, interstitium; Endo, endothelium; TIIC, 
Type II Cell; BEC, bronchial epithelial cell (Mudway and Kelly, 2000).  Reprinted from 
Mudway, IS and Kelly, FJ.  “Ozone: A Sensitive Issue”, Mol. Aspects of Med., Vol 21, 
issue 1-2, pp. 1-48, 2000 with permission from Elsevier. 
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 Figure 1.3:  Direct and indirect cellular effects due to O3. 
 
Once inhaled, O3 as well as O3-induced lipid peroxidation, lipid ozonation products 
(LOPs), and oxidation of proteins can cause direct cellular damage.  Oxidized soluble 
proteins may contribute to altered intercellular communication as well.  In addition, 
injured cells may release endogenous cell injury markers such as heat shock proteins 
(HSPs), fibronectin, and nitric oxide (NO) that may perpetuate cell damage or initiate 
cellular responsiveness.  Damaged and activated lung tissue produce pro-inflammatory 
mediators such as macrophage inflammatory protein (MIP)-2, tumor necrosis factor 
(TNF)-α, Interleukin (IL-) 6, and inducible nitric oxide synthase (iNOS).  These 
mediators signal neutrophilic infiltration and hyperpermeability responses, the hallmarks 
of O3-induced inflammation. 
 
 
 22
 Figure 1.4:  A quantitative trait locus (QTL) for O3-induced hyperpermeability. 
 
 
 
A genome wide scan using recombinant inbred mouse strains derived from O3-resistant 
(C3H/HeJ) and O3-susceptible (C57BL/6) mice phenotyped for hyperpermeability 
responsiveness identified a significant quantitative trait locus (QTL) located on murine 
chromosome 4.  Plot of the likelihood ratio 2 statistic (solid line) and additive regressive 
coefficient (dashed line).  Interval mapping was done by simple linear regression with 
Map Manager QTb27 to generate 2 and regression coefficient values.  The upper and 
lower horizontal lines in each plot represent significant and suggestive linkage thresholds, 
respectively, as determined by permutation test (Kleeberger et al., 2000). 
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 Figure 1.5:  TLR4 mediates pulmonary protein permeability caused by O3. 
 
Total BAL protein responses were compared in Tlr4-mutated (C3H/HeJ) and Tlr4-normal 
(C3H/HeOuJ) mice after 6, 24, 48 and 72 h exposure to 0.3 ppm O3.  Air controls were 
not statistically different from each other.  Data are presented as means ± SE (n = 5 - 16) 
* p < 0.05 air vs. O3. + , p < 0.05 C3H/HeJ vs. C3H/HeOuJ (Kleeberger et al., 2000). 
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Figure 1.6:  Proposed TLR4 signaling pathways in response to O3. 
 
Oxidation of TLR4 or other oxidants or ozonized by-products initiate TLR4 activation 
directly or indirectly.  The TLR4 complex includes MD-2 and lipopolysaccharide binding 
protein (LBP) in addition to CD14.  TLR4 activation is followed by adaptor recruitment 
and results in activation of ether the myeloid differentiation factor (MyD)-88-independent 
or MyD88-dependent signaling pathways.  The MyD88-independent pathway leads to 
DNA binding by interferon regulatory factor (IRF)-3 that transcriptionally activates 
interferon-beta (IFN-β) inducible genes.  MyD88-dependent signaling requires IL-1 
receptor associated kinase (IRAK)-1 and Toll-related activation factor (TRAF)-6 and 
leads to activated protein (AP)-1 and nuclear factor-kappa B (NF-κB) nuclear 
transcriptional activation and subsequent induction of pro-inflammatory gene products 
such as tumor necrosis factor (TNF), interleukin (IL-)1, IL-12, IL-18, IL-8, and inducible 
nitric oxide synthase (iNOS).  These mediators may direct PMN recruitment and cytokine 
production leading to increased inflammatory and adaptive immune responses. 
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Abstract 
Previous work has shown that a dominant negative mutation of the innate immune 
receptor toll-like receptor 4 (TLR4) decreases pulmonary hyperpermeability and 
inflammatory responses to ozone (O3) in the mouse.  However, the mechanism through 
which TLR4 mediates the effect of O3 remains unknown.  TLR4 works in conjunction with 
several extracellular accessory molecules, including CD14.  CD14 is critical for TLR4 
signaling in response to lipopolysaccharide (LPS) and respiratory syncytial virus.  However, 
the role of CD14 in O3-induced inflammation has not been investigated.  We hypothesized 
that O3-induced pulmonary inflammation and hyperpermeability are dependent on CD14.  To 
test this hypothesis, Cd14-deficient (Cd14-/-) and Cd14-sufficient (Cd14+/+) mice were 
exposed to 0.3 ppm O3 or filtered air.  Mean total protein concentration and numbers of 
polymorphonuclear leukocytes (PMN) in bronchoalveolar lavage fluid were significantly 
increased in Cd14+/+ and Cd14-/- mice after 48 and 72 hr exposure to O3 compared to air 
controls.  Lung mRNA expression of IL-6 and TNF-α increased in Cd14+/+ and Cd14-/- mice 
after O3.  However, no significant differences between strains were observed in lung injury 
parameters and TLR4-inducible inflammatory gene expression.  Total numbers of PMNs 
increased in response to LPS in Cd14+/+ mice but not Cd14-/- mice.  Results suggest that 
TLR4-mediated pulmonary injury responses to O3 are independent of CD14 and are therefore 
different from LPS responsiveness.  The mechanism underlying O3-induced pulmonary 
inflammation is unique from that of LPS
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Introduction 
Ozone (O3) is a prevalent constituent of air pollution.  Experimental and epidemiological 
studies have associated O3 exposures with exacerbation of asthma (Bayram et al., 2001; 
Hiltermann et al., 1997; McConnell et al., 2002; Neuhaus-Steinmetz et al., 2000) and 
increased mortality and morbidity (Touloumi et al., 1997).  Animal studies have shown that 
O3 induces airway inflammation, hyperpermeability, and airway hyperresponsiveness (Cho et 
al., 2000; Kleeberger, 1995; Plopper et al., 1998; Smith, 1986; Toward and Broadley, 2002).  
In turn, these responses are correlated with O3-induced production of inflammatory mediators 
tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), and macrophage inflammatory 
protein 2 (MIP-2) (Driscoll et al., 1993; Longphre et al., 1999) and their functional roles have 
been established (Cho et al., 2001; Johnston et al., 2005). 
We performed a genetic linkage analysis for susceptibility to O3-induced lung 
hyperpermeability that identified toll-like receptor 4 (Tlr4) as a candidate gene (Kleeberger et 
al., 1997).  C3H/HeJ (HeJ) mice possess a missense mutation in the third exon of the Tlr4 
gene that renders them resistant to lipopolysaccharide (LPS) (Poltorak et al., 1998) and we 
found that the mutation also confers resistance to O3-induced hyperpermeability compared to 
Tlr4-normal C3H/HeOuJ (OuJ) mice (Kleeberger et al., 2000).  However, the mechanism of 
TLR4-mediated responses to O3 remains unknown. 
The 11 known mammalian TLRs belong to the IL-1 receptor superfamily and function as 
innate immune receptors.  TLR4 responds to the non-variant lipid A component of LPS, a 
surface glycolipid of most gram-negative bacteria.  The lipid A moiety binds to LPS binding 
protein (LBP) that interacts with the membrane-anchored protein CD14 and MD2 (Akira and 
Takeda, 2004).  The LPS-bound LBP-CD14-MD2 complex interacts with TLR4 to initiate 
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downstream signaling via its intracellular toll-IL-1 receptor (TIR) domain.  Adaptor 
molecules, including myeloid differentiation factor-88 (MyD88) and interleukin-1 receptor 
associated kinase-1 (IRAK-1), bind to the TIR domain and phosphorylate tumor necrosis 
factor (TNF) receptor-associated factor-6 (TRAF-6) leading to nuclear factor kappa B (NF-
κB) nuclear translocation.  In the nucleus, NF-κB binds promoter sequences of 
proinflammatory cytokines (e.g., IL-6). 
CD14 and TLR4 are required for LPS-mediated pulmonary inflammation (da Silva 
Correia et al., 2001; Haziot et al., 1996; Wright et al., 1990). CD14 and TLR4 are also 
required to respond to respiratory syncytial virus (RSV) (Kurt-Jones et al., 2000) though this 
mechanism is independent of LBP.  However, the role of CD14 in TLR4-mediated 
inflammation induced by O3 has not been investigated.  The present study was designed to 
test the hypothesis that CD14 contributes to O3-induced lung injury and hyperpermeability.  
CD14-sufficient (Cd14+/+) and CD14-deficient (Cd14-/-) mice were exposed to 0.3 ppm O3 or 
air (48 or 72 hr).  O3-induced alterations in pulmonary injury phenotypes and TLR4-
downstream signal transducers were compared between the two mouse genotypes. 
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Materials and Methods 
Animals.  Female and male (6-8 weeks) Cd14+/+ (C57BL/6) and Cd14-/- (B6.129S-
Cd14th1Jm) were purchased from Jackson Laboratories (Bar Harbor, ME).  All mice were 
provided water and mouse chow (NIH-31) ad libitum.  All experimental procedures were 
conducted in accordance with approved NIEHS Animal Care and Use protocols. 
 
O3 Exposure.  Mice were exposed to 0.3 ppm O3 or filtered air for 48 or 72 hr, 23.5 
hr/day.  O3 was generated from ultra-high purity air (<1 ppm total hydrocarbons; National 
Welders, Inc., Raleigh, NC) using a silent arc discharge O3 generator (Model L-11, Pacific 
Ozone Technology, Benicia, CA).  Constant chamber air temperature (72 ± 3° F) and relative 
humidity (50 ± 15%) were maintained.  Water and mouse chow were provided during the 
exposure. 
 
LPS Aspiration.  Mice were lightly anesthetized with 3 % Isofluorane/Oxygen for 2 min.  
We administered 1.0 μg/kg of LPS (0111:B4, Sigma, St. Louis, MO) in a 50 μL volume or 
phosphobuffered saline (PBS, 50 μL/mouse) by oropharyngeal aspiration.  Mice were 
allowed to recover on warm wax pads for 24 hrs. 
 
Necropsy and Bronchoalveolar Lavage (BAL) Analysis.  Mice were euthanized (sodium 
pentobarbital, ip., 104 mg/kg) immediately following O3 exposure and up to 24 hrs after LPS 
exposure.  The right lung was lavaged four times with ice-cold Hanks' balanced salt solution 
(HBSS) (26.0 ml/kg, pH 7.2-7.4).  The left lung was snap frozen in liquid nitrogen.  
Recovered bronchoalveolar lavage fluid (BAL) was centrifuged (500 × g, 4°C, 10 min.).  
 31
BAL analysis followed standard laboratory protocols (Cho et al., 2001).  Briefly, mean total 
protein was determined from the supernatant via the Bradford Assay (BioRad, Hercules, 
CA).  Cell pellets were resuspended in 1 mL ice-cold HBSS and total cell numbers were 
counted with a hemacytometer.  A 200 μL aliquot was used to make cytospin slides (300 rpm 
for 10 min) (Shandon Southern Products, Pittsburgh, PA).  Slides were stained with Wright-
Giemsa stain (Diff-Quik; Baxter Scientific Products, McGaw Park, IL) for differential cell 
analysis. 
 
Reverse Transcriptase - Polymerase Chain Reaction (RT-PCR).  Total mRNA was 
isolated from lung homogenates using TRIzol reagent (Life Technologies, Gaithersburg, 
MD).  Five hundred ng of RNA from individual mice were reverse transcribed according to 
previously published protocols (Cho et al., 2001).  PCR amplification was performed with an 
aliquot of cDNA (10 µl).  Forward and reverse primers specific for mouse Il6, TNFα, TLR4, 
Mip-2, and Cd14 were used.  β-actin served as an internal control.  All primers were initially 
incubated at 94o for 5 minutes prior to a three-step cycle consisting of denaturation, 
annealing, and extension segments (Table 2.1).  Reactions were electrophoresed in 1.2 % 
agarose gels containing ethidium bromide. cDNA Bands were visualized and quantitated 
with a Bio-Rad Gel Doc 2000 system (Bio-Rad Laboratories, Hercules, CA).  The ratios of 
Il6, Mip-2, or Tnfα to β-actin cDNA were determined. 
 
Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction (Q-RT-PCR).  
Total RNA was isolated from left lung homogenates using the RNAeasy Midi Kit (Qiagen 
Inc., Valencia, CA) following the manufacturer’s instructions.  One μg of total RNA was 
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reverse transcribed into cDNA (50 μl reaction).  The ABI 7000 Sequence Detector (Applied 
Biosystems, Foster City, CA) was used to detect TNF-α and CD14 gene expression using 
qPCR TaqMan ® Gene Expression Power Syber Assays (Applied Biosystems, Foster City, 
CA).  Briefly, two μL of cDNA was amplified in a 20-μl reaction containing 10 μL of 2x 
PowerSyber Master Mix (Applied Biosystems, Foster City, CA) and 1 μL of custom specific 
primers for Tnf-α and Cd14 (Invitrogen, Carlsbad, CA).  18s ribosomal RNA was served as 
an internal control.  PCR was performed by 10 min incubation at 95 oC followed by 40 cycles 
of 95 oC-15 sec and 60oC-1 min (n = 9, data not shown). 
 
Western Blot.  Total lung protein was extracted from lung tissue homogenates in ice-cold 
RIPA buffer with phosphatase inhibitors of 100 nM sodium orthovanadate (10 μL/L), 
aprotinin (0.2 μL/mL), PMSF (10 μL/mL), leupeptin (50 μg/mL, 5 μL) and pepstatin (25 
μg/mL, 9 μL).  Aliquots of total proteins (30-80 μg) were subjected to Western blot analysis 
with specific primary antibodies (Santa Cruz Biotechnologies, Santa Cruz, CA) to TLR4 
(SC-16240), CD14 (SC-9150), MyD88 (SC-8197), IRAK-1 (SC-7883), and TRAF-6 (SC-
7221) with gentle agitation overnight at 4 oC.  Detection agents (SuperSignal West Pico 
Chemiluminescent Substrate, Pierce, IL) were added to the blot and exposed to BioMaxMR 
x-ray film (Kodak, Rochester, NY).  Intensity of Western blot bands was quantitated using 
the BioRad Gel Doc 2000 System. 
 
Enzyme-Linked Immunosorbant Assay. Protocols followed manufacturer’s instructions 
(R&D Systems, Minneapolis, MN). Briefly, 50 μL assay diluent and 50 μL of either cell-free 
BAL fluid or MIP-2 cytokine standards (500 – 7.8 pg/mL) were added to murine MIP-2 pre-
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coated 96-well ELISA plates. All samples were performed in duplicate and allowed to 
incubate for 2 h at room temperature.  Plates were washed and incubated with MIP-2 
conjugate for 2 h at room temperature.  Following further washes, 100 μL of substrate 
solution was added.  The reaction was stopped following a ½ hr incubation at room 
temperature in the dark and plates were measured at 450 nm on a Bio-Rad microplate reader 
(Hercules, CA).  The minimum detectable dose of murine MIP-2 was less than 1.5 pg/mL. 
Nuclear Protein Isolation and Electrophoretic Mobility Shift Assay (EMSA).  Nuclear 
extracts were prepared from right lung lobes following 48 hr of either air or 0.3 ppm O3 using 
a Nuclear Extraction Kit (Active Motif, Carlsbad, CA).  An aliquot (6 μg) of nuclear protein 
was incubated in a binding buffer (10mM Tris, pH 7.5, 50 mM NaCl, 1 mM EDTA, 5 % 
glycerol, 1 mM DTT, 0.2 μg PolydI-dC, 1 mM PMSF) in a total volume of 19 μl.  After 15 
min incubation, 1 μl (3 x 104 cpm) of [γ32P] dATP end-labeled oligonucleotide containing a 
NF-κB consensus sequence was added to the reaction and followed by 30 min incubation at 
room temperature.  The mixture was subjected to electrophoresis on a 4 % SDS-PAGE with 
0.25X TBE buffer.  The gels were autoradiographed at –70 °C.  To analyze specific binding 
of NF-κB subunits, nuclear proteins (6 μg) were pre-incubated with either 4 μg of anti-p65 
NF-κB antibody (sc-372X; Santa Cruz) or 4 μg of anti-p50 NF-κB antibody (sc-1190X; 
Santa Cruz), and processed for gel shift assay as described above. 
 
Statistics.  All data were expressed as group means ± SE.  The data were transformed, if 
necessary, to ensure normal data distribution and equal variance.  Two-way ANOVA was 
used to evaluate the effects of O3 exposure on pulmonary toxicity.  The factors were 
exposure (air or O3) and genotype (Cd14
+/+ or Cd14-/-).  The dependent variables were lung 
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protein concentration, PMN cell counts, and cytokine mRNA and protein expression.  The 
Student Newman Keuls a posteriori test was performed to compare group means.  All 
statistical analysis was performed using a commercial statistics package (SigmaStat, Systat 
Software, Point Richmond, CA).  Statistical significance was accepted at p < 0.05. 
 
Results 
CD14 is required for the PMN response to LPS.  To confirm the importance of CD14 to 
the pulmonary response to LPS and to serve as the positive control for the O3 experiments, 
we compared the inflammatory response to LPS in Cd14+/+ and Cd14-/- mice.  No significant 
differences in mean numbers of PMNs and mean total protein recovered in BAL were found 
between Cd14+/+ and Cd14-/- mice in response to saline (Figure 2.1).  Mean numbers of 
PMNs were significantly increased in Cd14+/+ mice 24 hr after aspiration of LPS compared 
to saline (Figure 2.1A).  However, mean numbers of PMNs were not significantly different 
between LPS- and saline-treated Cd14-/- mice.  Numbers of PMNs from LPS-treated groups 
were significantly higher in Cd14+/+ compared to Cd14-/- mice (Figure 2.1A).  Compared to 
corresponding saline controls, LPS did not cause a significant increase in total lung protein 
concentration in either genotype (Figure 2.1B). 
 
CD14 is not required for the PMN response to O3.  We tested the hypothesis that CD14 
contributes to the inflammatory response to O3 by exposing Cd14+/+ and Cd14
-/- mice to 
filtered air or 0.3 ppm O3 for up to 72 hrs continuously followed by assessment of 
inflammatory endpoints.  No significant differences in mean numbers of PMNs and total 
protein concentration recovered in BAL were found between Cd14+/+ and Cd14-/- mice in 
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response to air (Figure 2.2).  Mean numbers of PMNs and mean protein concentration were 
significantly elevated in Cd14+/+ and Cd14-/- mice after 48 and 72 hrs of 0.3 ppm O3 
compared to genotype-matched air controls (Figure 2).  However, we did not find a 
statistically significant interaction of treatment and strain on mean numbers of PMNs at 72 hr 
although an increase in the number of animals may help to further clarify this trend (Figure 
2.2A).  Protein hyperpermeability did not differ significantly between Cd14+/+ and Cd14-/- 
mice after O3 at either time point (Figure 2.2B). 
 
CD14 is not required for activation of TLR4 signaling intermediates in response to O3.  
To confirm that Cd14 was not present in Cd14-/- mice, we determined Cd14 mRNA and 
CD14 protein levels in response to air and O3 in both strains of mice.  As expected, neither 
Cd14 mRNA nor CD14 protein were expressed in Cd14-/- mice after air or O3 (data not 
shown).  We next determined that TLR4 and TLR4-associated signaling molecules (MyD88, 
IRAK-1, TRAF-6) were still intact in Cd14-/- mice.  Tlr4 mRNA expression was not different 
between the two genotypes of mice after air or O3 exposure (Figure 2.3A).  In addition, basal 
protein levels of MyD88, IRAK-1 and TRAF-6 were not different between Cd14+/+ and 
Cd14-/- mice.  In response to O3, MyD88 expression increased significantly compared to air 
in Cd14+/+ mice and was also significantly greater in Cd14+/+ compared to Cd14-/- mice 
(Figure 2.3B).  This trend is interesting but should be interpreted with caution since the 
MyD88 antibody used did not yield consistent results, despite an n of 6 and numerous 
replicates.  No effect of O3 on IRAK-1 or TRAF-6 protein levels was detected in Cd14+/+ or 
Cd14-/- mice (Figure 2.3C and 2.3D). 
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CD14 does not influence DNA binding activity of nuclear factor kappa B (NF-kB) in 
response to O3.  The transcription factor NF-κB is an effector of TLR4 and is activated in 
response to O3.  NF-κB controls induction of proinflammatory genes IL-6 and TNF-α.  We 
expected NF-κB levels to increase in response to O3.  In addition, we hypothesized if CD14 
contributed to O3-induced inflammation, then NF-κB activation would be attenuated in Cd14-
/- compared to Cd14+/+ mice.  Relative to air exposure, total NF-κB as well as specific p50 
and p65 binding were enhanced in Cd14+/+ and Cd14-/- mice after O3.  However, no 
differences in either total NF-κB, or supershifted p50 or p65 binding were found between 
genotypes (Figure 2.4). 
 
LPS but not O3 induces differential MIP-2 production in CD14+/+ and Cd14
-/- mice.  The 
neutrophil chemoattractant MIP-2 is known to increase in response to LPS and to O3. To 
confirm that LPS-induced MIP-2 production is dependent on CD14, we challenged Cd14+/+ 
and Cd14-/- mice with either LPS or saline.  MIP-2 expression was not different between 
Cd14+/+ and Cd14-/- mice after saline.  MIP-2 levels were 4.5 fold higher in Cd14+/+ mice 
compared to Cd14-/- mice after LPS (Figure 2.5A).  We then hypothesized that if CD14 
contributed to the inflammatory response to O3, MIP-2 would be attenuated in Cd14
-/- 
compared to Cd14+/+ mice after O3.  MIP-2 production increased significantly in response to 
O3 compared to air in both genotypes.  MIP-2 levels were, however, not significantly 
different between Cd14+/+ and Cd14-/- mice after O3 (Figure 2.5B). 
 
CD14 does not influence production of cytokines MIP-2, TNF-α, and IL-6 associated with 
TLR4 in response to O3.  MIP-2, TNF-α and IL-6 are pro-inflammatory cytokines that 
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increase in response to O3.  Moreover, TNF-α and IL-6 are induced via TLR4-mediated NF-
κB activation. We hypothesized that mRNA expression of these cytokines would be 
significantly higher in Cd14+/+ compared to Cd14-/- mice in response to O3.  No differences 
in mRNA expression of MIP-2, TNF-α, and IL-6 were found between Cd14+/+ and Cd14-/- 
mice after air exposure (Figure 2.6).  O3 significantly increased expression of these 
inflammatory mediators in Cd14+/+ and Cd14-/- mice over the corresponding air control 
levels.  However, no significant CD14 effect was detected in the O3-induced expression of 
these genes. 
 
Discussion 
O3 inhalation can increase the susceptibility of mice to bacterial infection and thus can 
alter the immune response in the lung, possibly by modulating alveolar macrophage function 
(Gilmour et al., 1993).  We previously demonstrated that the innate immune receptor TLR4 
contributes to O3-induced hyperpermeability in a mouse model (Kleeberger et al., 2000).  
Inasmuch as CD14 is required for TLR4-mediated signaling by LPS and RSV, the current 
study was designed to test the hypothesis that CD14 is also essential in O3-induced 
pulmonary hyperpermeability and inflammatory responses.  In contrast to our hypothesis, we 
found that O3-induced increases in mean numbers of PMNs and total protein were not 
significantly different between Cd14+/+ and Cd14-/- mice.  Furthermore, we observed that the 
expression of downstream proinflammatory cytokines MIP-2, IL-6 and TNF-α was not 
different in Cd14+/+ and Cd14-/- mice after exposure to O3. 
Clinical studies have demonstrated that constitutive CD14 levels correlate with the 
magnitude of PMN influx in response to small doses of inhaled LPS (Alexis et al., 2001).  
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Tasaka et. al. (2003) and Jiang et. al. (2005) confirmed that CD14 is critical for the TLR4-
mediated response to LPS via MyD88-dependent and MyD88-independent pathways (Jiang 
et al., 2005; Tasaka et al., 2003).  On the cell surface, CD14 acts in concert with 
lipopolysaccharide binding protein (LBP) to bring the lipid A portion of LPS into close 
proximity to MD2 that, in turn, complexes to the extracellular domain of TLR4 (Schumann, 
1992; Wright et al., 1990).  CD14 increases the sensitivity of the TLR4-MD2 complex to 
LPS (Akashi et al., 2000; da Silva Correia et al., 2001).  In addition, Kurt-Jones et. al. 
established that CD14 and TLR4 are required for response to RSV (Kurt-Jones et al., 2000) 
and suggest that CD14 and TLR4 do not require LBP in some protocols.  Signaling causes 
nuclear translocation of NF-κB and activated protein-1 (AP-1) to induce proinflammatory 
gene expression.  
In the present study, IRAK-1 and TRAF-6 expression did not differ significantly between 
Cd14+/+ and Cd14-/- mice after O3.  Similarly, O3-induced NF-κB binding did not differ 
between Cd14+/+ and Cd14-/- mice.  These results suggest that TLR4 downstream signaling 
and activation in response to O3 occurs independently of CD14.  We also determined that 
Cd14 gene disruption did not affect transcription or translation of TLR4.  TLR4 can activate 
MyD88-dependent and MyD88-independent signaling cascades (Akira and Hoshino, 2003; 
Kawai et al., 2001; Kovarik et al., 1998).  Although we did not assess whether O3-induced 
MyD88-independent signaling requires CD14, it is unlikely that CD14 functionally affects 
the MyD88-independent pathway given that differential expression of downstream effectors 
and inflammation were not observed between Cd14+/+ and Cd14-/- mice in response to O3. 
Our findings are consistent with those of Hollingsworth et. al. (2004) where no 
differences in O3-induced inflammation were found between Tlr4-sufficient and Tlr4-deleted 
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mice (Hollingsworth et al., 2004).  The Tlr4-deleted and Cd14-/- mice were on the same 
genetic background (C57BL/6) and both genes have previously been shown to be critical to 
the response to LPS (Haziot et al., 1996; Hollingsworth et al., 2004).  Genetic background 
may modulate the response to O3.  The role of CD14 should be tested in a C3H model, the 
same background as the C3H/HeJ (Tlr4-mutated) strain that has shown differential 
susceptibility to O3 (Kleeberger et al., 2001).  To test this hypothesis, we would generate 
CD14-deficient mice on the C3H background by repeated backcross matings and retest our 
current hypothesis.  A second possibility would be to administer an in vivo CD14-depleting 
antibody to C3H mice and reassess inflammatory responses to O3 or air in comparison to 
C3H animals that received sham antibody. 
We found that LPS-induced PMN inflammation was significantly greater in Cd14+/+ mice 
compared to Cd14-/- mice, and confirmed that LPS-induced neutrophilia is dependent on 
CD14.  Haziot et. al. demonstrated that LPS-resistant Cd14-/- mice produce less TNF-α and 
IL-6 compared to control mice in response to LPS (Haziot et al., 1996).  Consistent with 
these observations, we found that LPS-induced levels of the neutrophil chemoattractant MIP-
2, a mouse analog of IL-8, differed significantly between Cd14+/+ and Cd14-/- mice.  
However, MIP-2 protein production as well as IL-6 and TNF-α mRNA were not different 
between the two mouse genotypes after O3.  These results suggest that CD14 does not 
functionally contribute to O3-induced inflammatory mediator production. 
Polymorphisms in CD14 are associated with differential responsiveness to LPS (Baldini et 
al., 2002) and increased risk for atopy in childhood (Baldini et al., 2002; Kleeberger and 
Peden, 2005; Vercelli, 2002).  Interestingly, Raby et. al. (2002) found that polymorphisms in 
TLR4 (D299G) are not associated with asthma or atopy-related phenotypes while other 
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polymorphisms seem to be associated with increased severity to atopy (Raby et al., 2002).  It 
is possible that the role of TLR4 in LPS-mediated atopy may be dependent on the dose or 
timing of exposure.  Moreover, these studies suggest that CD14 may have a distinct role in 
the atopic response compared to TLR4 and suggest that these two cell-surface proteins may 
be stimulus-specific. 
CD14-independent LPS recognition has been suggested in recent studies.  One model 
describes a CD14-independent, MyD88 dependent pathway that leads to the induction of 
TNF-α and IL1-β (Perera et al., 1997).  Taxol, an antitumor agent mechanistically linked to 
LPS, has also been shown to induce CD14-dependent and CD14-independent pathways in 
Cd14-/- mice (Tasaka et al., 2003).  In addition, Triantafilou et. al. determined that TLR4 
interacts with a heterogeneous activation cluster consisting of heat shock proteins 70 and 90 
(HSP70, HSP90), chemokine receptor 4 (CXCR4), and growth differentiation factor 5 
(Triantafilou et al., 2001).  In particular, HSP70 has been associated with the response to O3 
(Su and Gordon, 1997; Wong et al., 1996) and is thought to be a potential ligand of TLR4 
(Vabulas et al., 2001).  It is possible that TLR4-mediated O3-induced inflammation may 
occur when O3 interacts directly or indirectly with HSP70 that then combines with other 
extracellular proteins to form a CD14-independent heterogeneous activation cluster.  
However, further studies are necessary to confirm this hypothesis. 
Numbers of PMNs were elevated in Cd14-/- mice compared to Cd14+/+ mice after 72 h O3 
but this increase was not statistically significant.  We attribute this difference to a number of 
different factors.  The soluble form of CD14 (sCD14) attenuates LPS-induced macrophage 
activation by competitively binding LPS (Le-Barillec et al., 1999; Wurfel et al., 1995) and is 
therefore thought to protect against inflammation.  The elevated PMNs in Cd14-/- mice could 
 41
be due at least partially to the absence of sCD14 in the knockout animals.  In addition, CD14 
is part of a macrophage recognition system that leads to phagocytosis of apoptotic cells 
(Devitt et al., 2004; Schlegel et al., 1999).  Apoptotic cells may occur as a result of oxidative 
damage sustained by exposure to O3 (Kirichenko et al., 1996).  The elevated number of 
PMNs in Cd14-/- mice could also be due to the reduced ability to clear apoptotic cells in these 
animals. 
In conclusion, we have shown that TLR4-mediated lung injury occurs independently of 
CD14 in response to O3.  Our results suggest that molecular mechanisms of O3 and LPS-
stimulated TLR4 signaling are stimulus specific.  Direct or indirect oxidative damage to the 
TLR4 receptor itself may contribute to differential response to O3.  Investigating mechanisms 
through which TLR4 signaling modifies susceptibility responses to O3, will improve 
understanding of the innate immune response to airway injury. 
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 Figure 2.1:  Effect of targeted gene disruption of Cd14 on LPS-induced inflammation. 
 
Figure represents changes in number of polymorphonuclear leukocytes (PMNs) (A) and total 
protein concentration (B) recovered in the bronchoalveolar lavage fluid (BALF) between air 
and 0.3 ppm O3 in Cd14+/+ and Cd14-/- mice.  Values are means ± SE (n = 5/group). * P < 
0.05, saline vs. 1.0 μg/kg LPS.  + P < 0.05, Cd14+/+ vs. Cd14-/-. 
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 Figure 2.2:  Effect of targeted gene disruption of Cd14 on O3-induced inflammation. 
 
 
Figure represents changes in numbers of polymorphonuclear leukocytes (PMNs) (A) and 
total protein concentration (B) from recovered bronchoalveolar lavage fluid (BALF) of 
Cd14+/+ and Cd14-/- mice exposed to air or 0.3 ppm O3.  Data are presented as means ± SE (n 
= 5 /group).  * p < 0.05, air vs. 0.3 ppm O3. 
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Figure 2.3:  Effect of targeted gene disruption of Cd14 on TLR4-signaling molecules in 
response to O3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure represents protein levels of TLR4 (A), MyD88 (B), IRAK-1 (C), and TRAF-6 (D) in 
response to air or 0.3 ppm O3 in Cd14+/+ and Cd14-/- mice.  Values are means ± SE (n = 6 per 
group).  All values were normalized to actin. Air vs. O3 * P < 0.05; Cd14+/+ vs. Cd14
-/- + P < 
0.05. 
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Figure 2.4:  NF-κB specific DNA binding in response to 0.3 ppm O3 in Cd14+/+ and Cd14-/- 
mice 
 
Figure represents NF-κB (A) and NF-κB-specific subunits p50 (B) and p65 (C) that bind to 
DNA in response to 0.3 ppm O3 in Cd14+/+ and Cd14
-/- mice.  Each lane represents nuclear 
protein pooled from three representative animals of each treatment group and is 
representative of three trials.  SB, shifted band; SSB, supershifted band; FP, free probe. 
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Figure 2.5:  MIP-2 levels in Cd14+/+ and Cd14-/- mice in response to LPS or O3. 
 
 
Figure represents MIP-2 levels in Cd14+/+ and Cd14-/- mice in response to saline vs. 1.0 
μg/kg LPS (A) or air vs. 0.3 ppm O3 (B).  Values are means ± SE (n = 5 per group).   * P < 
0.05, Air or saline vs. 1.0 μg/kg LPS or 0.3 ppm O3, + P < 0.05, Cd14+/+ vs. Cd14-/-. 
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Figure 2.6:  O3-induced proinflammatory gene expression in Cd14+/+ and Cd14
-/- mice. 
48 
 
MIP-2 (A), Tnf-α (B), and Il6 (C) mRNA expression in Cd14+/+ and Cd14-/- mice after air or 0.3 ppm O3 exposure.  Data are presented 
as means ± SE (n = 3-5 per group). Air vs. 0.3 ppm O3: *, P < 0.05. 
 
Table 2.1: cDNA primer sequences and PCR conditions 
Gene Primer Sequences GeneBank 
ID 
Amplified 
Size (bp) 
Annealing 
Temp (°C) 
PCR 
Cycle No. 
β-actin Forward GTG GGC CGC TCT AGG CAC CA      
Reverse CGG TTG GCC TTA GGG TTC AGG 
 
328504 221 55 27 
Tlr4   Forward CCA ATT GAC TTC ATT CAG A 
Reverse CAT TTT TAA GTC TTC TCC A 
 
21898 782 57 30 
Tnf-α Forward ATG AGC ACA GAA AGC ATG ATC 
Reverse TAC AGG CTT GTC ACT CGA ATT 
 
21926 276 55 30 
Cd14 Forward ATC CGA AGC CAG ATT GGT CCA   
Reverse AAC TGA GAT CCA CGA GCG TGA 
 
12475 782 65 30 
Il-6 Forward AAG AAC GAT AGT CAA TTC CA      
Reverse GAT CTC AAA GTG ACT TTT AG 
 
16193 649 57 40 
Mip-2  Forward AGC TGC GCT GTC AAT GCC TGA    
Reverse GGC ACA TCA GGT ACG ATC CAG  
20310 288 57 30 
TLR4, Toll-like receptor 4; IL, Interleukin; TNF, tumor necrosis factor; MIP, macrophage inhibitory 
protein; Temp, temperature 
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Abstract  
Ambient ozone (O3) induces airways inflammation and alters immune responses.  
Interleukins (IL-) 12 and 18 regulate production of inflammatory cytokines.  Previous work 
has shown that the innate immune receptor, toll-like receptor 4 (TLR4) positively modulates 
O3-mediated inflammation.  The link between TLR4 and IL-12 and IL-18 production in 
response to O3 has not been shown.  We hypothesized that TLR4 can mediate O3-induced 
Il12 and Il18 expression and that deficiencies in IL-12 and IL-18 would attenuate O3-induced 
inflammation.  Tlr4-normal (OuJ), Tlr4-mutated (HeJ), IL-12-alpha-deficient (Il12α-/-), IL-
12-beta-deficient (Il12β-/-), and IL-18 receptor-deficient (Il18r1-/-) mice and corresponding 
wildtype (+/+) controls were exposed continuously to 0.3 ppm O3 or filtered air for up to 72 
hrs.  Immediately following exposure, differential cell counts were assessed in 
bronchoalveolar lavage fluid (BALF).  Tumor necrosis factor (TNF-α) gene expression was 
determined in whole lung homogenates.  Compared to respective +/+ controls, no significant 
differences in BALF cells or total protein (a marker of lung permeability) were found 
between HeJ, Il12α-/-, Il12β-/-, or Il18r1-/- mice after air exposures.  Il12 expression was not 
different at baseline between OuJ and HeJ mice.  O3-induced Il12 expression was higher in 
OuJ than HeJ mice.  Il18 expression was elevated in OuJ compared to HeJ mice at baseline 
and after O3.  O3 caused significant increases in BAL polymorphonuclear leukocytes (PMNs) 
and total protein at 48 and 72 hr in Il12α-/-, Il12β-/-, and Il18r1-/- mice and +/+ controls, 
relative to respective air exposed control mice.  However, compared to respective O3-
exposed +/+ mice, the number of PMNs was significantly lower in Il12β-/- mice, and 
significantly greater in Il18r1-/- mice after exposure to O3.  Tnf-α mRNA expression was also 
significantly increased in lung homogenates from O3-exposed Il18r1-/- mice compared to 
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Il18r1+/+ mice after exposure to O3.  Results demonstrated that TLR4 may control expression 
of the regulatory cytokines Il12 and Il18.  IL-12β contributes significantly to the pulmonary 
inflammatory response induced by exposure to 0.3 ppm O3.  In contrast, deletion of IL-18R1 
enhanced O3-induced inflammation, perhaps through upregulation of Tnf-α expression.  
Results suggest that IL-12 and IL-18R1 modulate pulmonary inflammation after oxidant 
injury. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: TLR4, IL-12, IL-18, IL-18R1, ozone, lung, inflammation 
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Introduction 
Ozone (O3) is a prevalent constituent of air pollution.  Experimental and epidemiological 
studies have associated O3 exposures with exacerbation and increased incidence of asthma 
(Bayram et al., 2001; Hiltermann et al., 1997; McConnell et al., 2002; Neuhaus-Steinmetz et 
al., 2000) and increased mortality and morbidity (Touloumi et al., 1997).  Animal studies 
have shown that O3 induces airway inflammation, hyperpermeability, and airway 
hyperresponsiveness (Kleeberger, 1995; Plopper et al., 1998; Smith, 1986; Toward and 
Broadley, 2002).  O3 inhalation can also increase the susceptibility of mice to bacterial 
infection and thus can alter the immune response in the lung (Gilmour et al., 1993).  Pre-
exposure to O3 may sensitize individuals to a secondary stimulus, resulting in prolonged 
inflammation, and expression of cytokine and chemokine messages (Johnston et al., 2002). 
The regulatory cytokines interleukin (IL-) 12 and IL-18 have been proposed to correlate with 
O3-induced inflammation and production of inflammatory mediators such as tumor necrosis 
factor alpha (TNF-α) (Cho et al., 2001).  However, the functional role of these cytokines in 
the pathogenesis of O3-induced lung injury has not been investigated. 
Positional cloning identified toll-like receptor 4 (Tlr4) as a candidate gene for 
susceptibility to O3-induced lung hyperpermeability (Kleeberger et al., 1997).  C3H/HeJ 
(HeJ) mice possess a missense mutation in the third exon of Tlr4 (Poltorak et al., 1998) and 
are resistant to O3-induced hyperpermeability compared to Tlr4-normal C3H/HeOuJ (OuJ) 
mice (Kleeberger et al., 2000).  LPS, a TLR4 ligand, can induce IL-12 and IL-18 expression 
in vitro via the c-Rel subunit of NF-κΒ (Mason et al., 2002; Sanjabi et al., 2000).IL-12 is a 
heterodimeric protein consisting of p35 (IL-12α) and p40 (IL-12β) subunits (Gately et al., 
1998; Trinchieri, 2003) and enables communication between the innate and adaptive 
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responses.  IL-12 is produced by B-cells and macrophages, promotes Th1 responses, and 
suppresses Th2 responses by stimulating naïve T cells to differentiate into interferon gamma 
(IFN-γ) secreting T-cells (Gately et al., 1998). 
IL-18, initially called IFN-γ inducing factor, is an 18 kD single polypeptide that shares 
structural homology with IL-1 (Okamura et al., 1995).  It is derived from the enzymatic 
cleavage of a 23kD precursor by the caspase IL-1beta converting enzyme (ICE) that is 
activated by LPS (Schumann et al., 1998) and is expressed in macrophages, T-cells, B-cells 
and airway epithelium (Cameron et al., 1999).  IL-18 has been associated with rheumatoid 
arthritis (Liew, 2001), LPS-induced liver injury (Sakao et al., 1999), and asthma (Wild et al., 
2000).  In humans, low levels of IL-18 have recently been associated with asthma and 
sarcoidosis (Ho et al., 2002).  The heterodimeric IL-18 receptor (IL-18R1) is expressed on 
macrophages and naïve T-cells and shares structural homology with other IL-1 superfamily 
members IL-1R and TLR4.  IL-18R1 has a ligand binding subunit (IL1Rrp or IL-18Rβ) and a 
signal transducing unit (IL-18acPL, IL-18Rα).  The IL-18 Receptor-α subunit uses the 
MyD88, IRAK, TRAF6, NF-κΒ pathway and cellular levels of this subunit are highest in 
activated Th1 cells (Akira, 2000). 
IL-12 and IL-18 are regulatory cytokines thought to bridge innate and adaptive immune 
responses due to their roles in inflammatory and T-cell mediated responses (Hofstra et al., 
1998; Lewkowich et al., 2005; Wang et al., 2004).  The objective of this study is to determine 
whether these cytokines are under the regulatory control of TLR4 and, in turn, whether these 
cytokines contribute to innate responses (neutrophilic inflammation) in response to O3.  
Because IL-12 and IL-18 have potential roles in TLR4-mediated responses to LPS (Dobashi 
et al., 2001; Kollet and Petro, 2006) and TLR4 also mediates inflammatory responses to O3, 
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we hypothesized that these cytokines would be differentially expressed in Tlr4-normal and 
Tlr4-mutated mice and further, that these cytokines are important in O3-induced pulmonary 
inflammatory responses. 
 
Materials and Methods 
Animals.  Male (6-8 weeks) C3H/HeOuJ (OuJ), C3H/HeJ (HeJ), Il12a-/- (B6.129S1-
Il12αtm1Jm), Il12β-/- (B6.129S1-IL12βtm1Jm/J), IL18-/- (B6.129P2-Il18 /Jtm1Aki ), Il18r1-/- 
(B6.129P2-Il-18R1tm1Aki/J), and C57BL/6 (Il12a+/+ , Il12β+/+, IL18-/-, and Il18r1+/+) were 
purchased from Jackson Laboratories (Bar Harbor, ME).  All mice were provided water and 
mouse chow (NIH-31) ad libitum.  All experimental procedures were conducted in 
accordance with approved NIEHS Animal Care and Use protocols. 
 
O3 Exposure.  Mice were exposed to 0.3 ppm O3 or filtered air for 6, 24, 48 or 72 hr, 23.5 
hr/day.  O3 was generated from ultra-high purity air (< 1 ppm total hydrocarbons; National 
Welders, Inc., Raleigh, NC) using a silent arc discharge O3 generator (Model L-11, Pacific 
Ozone Technology, Benicia, CA).  Constant chamber air temperature (72 ±3° F) and relative 
humidity (50 ± 15%) were maintained.  Water and mouse chow were provided during the 
exposure. 
 
Necropsy and Bronchoalveolar Lavage (BAL) Analysis.  Mice were euthanized (sodium 
pentobarbital, ip., 104 mg/kg) immediately following O3 exposure.  The right lung was 
lavaged four times with ice-cold Hanks' balanced salt solution (HBSS) (26.0 ml/kg, pH 7.2-
7.4).  The left lung was snap frozen in liquid nitrogen.  Recovered bronchoalveolar lavage 
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fluid (BALF) was centrifuged (500 × g, 4°C, 10 min.).  BALF protein and cell analysis 
followed standard laboratory protocols (Cho et al., 2001).  Briefly, mean total protein was 
determined from the supernatant via the Bradford Assay (BioRad, Hercules, CA).  Cell 
pellets were resuspended in 1 mL ice-cold HBSS and total cell numbers were counted with a 
hemacytometer.  A 200 μL aliquot was used to make cytospin slides (300 rpm for 10 min) 
(Shandon Southern Products, Pittsburgh, PA) and slides were stained with Wright-Giemsa 
stain (Diff-Quik; Baxter Scientific Products, McGaw Park, IL) for differential cell analysis. 
 
Reverse Transcriptase - Polymerase Chain Reaction (RT-PCR).  Total mRNA was 
isolated from lung homogenates using a Qiagen Midi-RNA extraction kit (Valencia, CA).  
One microgram of total lung RNA from individual mice were reverse transcribed according 
to previously published protocols (Cho et al., 2001).  PCR amplification was performed with 
an aliquot of cDNA (10 µl) using forward and reverse primers specific for mouse Il12p40, 
Il18, and TNF-α (Table 1).  β-actin was amplified as an internal control.  Reactions were 
electrophoresed in 1.2 % agarose gels.  cDNA Bands were visualized and quantitated with a 
Bio-Rad Gel Doc 2000 system (Bio-Rad Laboratories, Hercules, CA).  The cDNA intensity 
ratios of each gene to β-actin were determined.  
 
Histological analysis:  Left lungs were inflated with 10% formalin, removed en bloc, and 
immersed in 10% formalin.  After 24 hrs, lungs were cut into three cross sections, and 
processed for microscopic slides.  Five micron (μM) thick lung sections were stained with 
hematoxylin and eosin (H&E).  The extent of peribronchiolar and perivascular inflammation 
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in Il12β-/ and Il18r1-/- compared to Il12β+/+and Il18r1+/+ mice respectively was qualitatively 
assessed with the assistance of a pathologist. 
 
Nuclear Protein Isolation and Electrophoretic Mobility Shift Assay (EMSA).  Nuclear 
extracts were prepared from left lung lobes following 6, 24 or 72 hr exposure to 0.3 ppm O3 
or filtered air using a Nuclear Extraction Kit (Active Motif, Carlsbad, CA).  An aliquot (6 
μg) of nuclear protein was incubated in a binding buffer (10mM Tris, pH 7.5, 50 mM NaCl, 
1 mM EDTA, 5 % glycerol, 1 mM DTT, 0.2 μg PolydI-dC, 1 mM PMSF) in a total volume 
of 19 μl.  After 15 min incubation, 1 μl (3 x 104 cpm) of [γ32P] dATP end-labeled 
oligonucleotide containing a NF-κB or AP-1 consensus sequence was added to the reaction 
and followed by 30 min incubation at room temperature.  The mixture was subjected to 
electrophoresis on a 4 % SDS-PAGE with 0.25X TBE buffer.  The gels were 
autoradiographed at –70° C.  To analyze specific binding of NF-κB subunits, nuclear 
proteins (6 μg) were pre-incubated with either 4 μg of anti-p65 NF-κB antibody (sc-372X; 
Santa Cruz), and processed for gel shift assay as described above. 
 
Statistics.  All data were expressed as group means ± SE.  The data were transformed, if 
necessary, to ensure normal data distribution and equal variance.  Two-way ANOVA was 
used to evaluate the effects of exposure (air or O3) or genotype (Il12a, Il12β, Il18r1+/+ or 
OuJ vs. Il12α-/- Il12β-/-, Il18r1-/- or HeJ) on pulmonary toxicity.  The dependent variables 
were lung protein concentration, PMN cell counts, and cytokine mRNA and protein 
expression.  The Student Newman Keuls a posteriori test was performed to compare group 
means.  All statistical analysis was performed using a commercial statistics package 
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(SigmaStat, Systat Software, Point Richmond, CA).  Statistical significance was accepted at 
p < 0.05. 
 
Results 
Il12β and Il18 expression in OuJ and HeJ mice.  Il12β mRNA expression was not 
different between C3H/HeOuJ and C3H/HeJ mice after exposure to air (Figure 3.1A).  
However, Il12β mRNA expression was significantly higher in C3H/HeOuJ mice compared to 
C3H/HeJ mice after 24, 48 and 72 hr exposure to O3.  Il18 mRNA expression was 
significantly higher in C3H/HeOuJ mice compared to C3H/HeJ mice after air exposure.  Il18 
mRNA remained significantly higher in C3H/HeOuJ mice compared to C3H/HeJ mice 
during O3 exposure, and O3 significantly increased Il18 mRNA at 72 hr (Figure 3.1B). 
 
Contribution of IL-12 to the PMN response to O3.  To determine the role of IL-12 p35 
(IL12α) and p40 (IL12β) subunits in O3-induced inflammation, we compared BALF cell 
profiles and protein in Il12α+/+, Il12β+/+, Il12α−/−,  and Il12β−/−  mice after exposure to air 
and O3.  No differences in mean numbers of PMNs and mean total protein recovered in 
BALF were found between Il12a+/+ and Il12a-/- mice after exposure to filtered air.  Relative 
to air controls, total numbers of PMNs and protein increased significantly in Il12a+/+ and 
Il12a-/- mice after 48 and 72 hr exposure to O3, however no significant differences were 
found between genotypes (Figures 3.2A and B).  No differences in mean numbers of PMNs 
and mean total protein recovered in BALF were found between Il12β+/+ and Il12β-/- mice 
after exposure to air.  However, compared to respective air controls, total numbers of PMNs 
and protein increased significantly in Il12β+/+ and Il12β-/- mice after 48 and 72 hr exposure to 
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O3 (Figures 3.2C and D).  Further, total numbers of PMNs were significantly decreased in 
Il12β-/- compared to Il12β+/+ mice after 48 and 72 hr exposure to O3 (Figure 3.2C).  No 
differences in mean total protein were found between the two genotypes after O3 (Figure 
2D). 
 
Peribronchiolar and perivascular inflammation in Il12β+/+ and Il12β-/- mice.  After 
exposure to air, no differences in lung histology were found between Il12β+/+ and Il12β-/- 
mice.  Compared to air-exposed Il12β+/+ and Il12β-/- mice, perivascular and peribronchiolar 
inflammation was found in both genotypes after 48 and 72 hr exposure to O3 (Figure 3.3).  
However, pulmonary inflammation was attenuated in Il12β-/- mice compared to similarly-
exposed Il12β+/+ mice (Figure 3.3). 
 
Role of Il18 and Il18r1 in the PMN response to O3.  IL-18 is a ligand for IL18 receptor, a 
member of the IL-1 superfamily.  To further characterize the functional role of IL-18 and its 
receptor, we compared pulmonary responses between Il18+/+ and Il18-/- (Table 3.2) as well as 
between Il18r1+/+ and Il18r1-/- mice exposed to filtered air or O3 (Figures 3.4A and B).  
Mean numbers of PMNs were significantly increased in response to O3 compared to air in 
Il18+/+ and Il18-/- mice.  However, there was no significant difference in O3-induced 
neutrophilic inflammation between Il18+/+ and Il18-/- mice (Table 3.2).  Mean numbers of 
PMNs and mean protein concentration were significantly elevated in Il18r1+/+ and Il18r1-/- 
mice exposed to O3 for 48 and 72 hrs compared to genotype-matched air controls (Figures 
3.4A and B).  In addition, significantly greater numbers of PMNs were found in Il18r1-/- 
compared to Il18r1+/+ mice after 72 hr exposure to 0.3 ppm O3 (Figure 3.4A).  Mean BALF 
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protein concentration did not differ significantly between Il18r1+/+ and Il18r1-/- mice after 48 
or 72 hr exposure to O3 (Figure 3.4B). 
 
Peribronchiolar and perivascular inflammation in Il18r1+/+ and Il18r1-/- mice.  In 
response to air, no inflammation occurred in Il18r1+/+ and Il18r1-/- mice.  Compared to 
respective air-exposed control mice, O3 caused perivascular and peribronchiolar 
inflammation to increase in Il18r1+/+ and Il18r1-/- mice.  However, consistent with the BAL 
results above, inflammation was markedly enhanced in Il18r1-/- compared to Il18r1+/+ mice 
(Figure 3.5). 
 
TNFα levels in Il18r1-/- compared to Il18r1+/+ mice after 72 hr O3.  We previously found 
that Tnfα accounts for a significant portion of the PMN response to O3 in mice (Kleeberger et 
al., 1997).  To determine whether differences in Tnfα expression may account for the 
differential inflammatory response in Il18r1+/+ and Il18r1-/- mice, we measured Tnfα mRNA 
in lung homogenates in both genotypes after air and O3.  Tnfα expression did not differ 
significantly between the two genotypes after exposure to air (Figure 3.6).  Relative to 
respective air-exposed controls, Tnfα expression was significantly increased after 72 hr of 
continuous O3 in Il18r1-/- mice.  After 72 hr O3, Tnfα expression was significantly higher in 
Il18r1-/- compared to Il18r1+/+ mice. 
 
NF-κB activation in Il18r1-/- compared to Il18r1+/+ mice after exposure to O3.  We 
previously found that O3-induced inflammation mediated through TNF-α signaling involves 
NF-κB and AP-1 DNA binding (Cho et al., 2006).  As a member of the IL-1 superfamily, IL-
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18R1 shares many signaling components, including NF-κB.  IL-18 signaling may also be 
mediated by MAPK signaling (Nakanishi et al., 2001), detectable by AP-1 activation.  We 
hypothesized that NF-κB and AP-1 activation would be elevated in Il18r1-/- mice compared 
to Il18r1+/+ mice after O3 exposure, concurrent with increased neutrophilic inflammation in 
Il18r1-/- mice.  NF-κB total binding was elevated in Il18r1+/+ compared to Il18r1-/- at 
baseline and in response to O3 (Figure 3.7A and B).  However, specific p65 binding 
(indicated by supershifted bands) was increased in response to O3 compared to air controls  
and O3-induced specific p65 binding was higher in Il18r1+/+ compared to Il18r1-/- mice 
(Figure 3.7B).  AP-1 total binding was not different between the two genotypes at baseline.  
While AP-1 DNA binding was elevated in response to O3 compared to air, no differences due 
to genotype were determined (Figure 3.7C). 
 
Discussion 
We previously demonstrated that TLR4 contributes to O3-induced inflammation and 
hyperpermeability (Kleeberger et al., 2000).  The molecular mechanisms underlying O3-
mediated hyperpermeability have been linked to iNOS (NOS2) and TLR4-associated Nos2 
mRNA expression (Kleeberger et al., 2001).  However the TLR4 contribution to the innate 
immune response remains unclarified.  IL-12 and IL-18 are regulatory cytokines thought to 
prime adaptive immune cells by modulating the Th1-Th2 cytokine profile (Kitasato et al., 
2004).  Both cytokines are produced by macrophages and have been associated with lung 
injury induced by LPS, a TLR4 ligand (Dobashi et al., 2001; Kollet and Petro, 2006; Sakao et 
al., 1999).  The present study demonstrated that the production of Il12 and Il18 is dependent 
on TLR4.  Moreover, inflammatory responses to O3 in mice differ with targeted disruption of 
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Il12β and Il18r1, and suggest a pro-inflammatory role for IL-12 and an anti-inflammatory 
role for IL-18R1 in this model. 
As a generalized receptor, TLR4 can initiate innate immune responses to LPS (Poltorak et 
al., 1998), respiratory syncytial virus (RSV) (Kurt-Jones et al., 2000), particles (Cho et al., 
2005) and heat shock protein-mediated cell death (Triantafilou and Triantafilou, 2004).  In 
addition, TLR4 is known to control activation of Th1 adaptive immune responses (Schnare et 
al., 2001) and probably Th2 driven responses to inhaled allergen (Eisenbarth et al., 2002).  
The TLR4 ligand LPS activates macrophages to release IL-12 (Brunda, 1994; Trinchieri, 
2003) and IL-18 (Nakanishi et al., 2001).  Together, these innate immune response effectors 
mediate protective immunity.  In the present study, we showed that IL-12 and IL-18 mRNA 
expression was significantly higher in C3H/HeOuJ mice compared to C3H/HeJ mice in 
response to O3.  O3-induced IL-18 protein levels were also dependent on TLR4 activation.  
Moreover, IL-18 mRNA expression was significantly elevated in C3H/HeOuJ mice 
compared to C3H/HeJ mice at baseline.  These data support a role for TLR4 in production of 
IL-12 and IL-18, and suggest that these two cytokines may contribute to O3-induced immune 
responses. 
IL-12 stimulates interferon-gamma (IFN-γ) production, favors differentiation of T helper 
1 (Th1) cells and has been linked to T-cell mediated diseases such as collagen-induced 
arthritis (Bradley et al., 2002; Malfait et al., 1998).  IL-12 is known to bridge innate and 
adaptive immune responses as it is produced by macrophages, and binds to specific receptors 
expressed on activated T-cells (Brunda, 1994; Gately et al., 1998).  Neutralization of IL-12 
via anti-IL-12 antibody prevented lethality in an acute LPS model (Ozmen et al., 1994).  We 
tested the functional relevance of IL-12 in O3-induced inflammation by comparing 
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inflammatory responses in Il12 p35-/- (Il12α−/−) and Il12 p40-/- (Il12β−/−) mice and their 
wildtype counterparts after exposure to air and 0.3 ppm O3.  O3-induced neutrophilic 
inflammation was significantly attenuated in Il12β-/- but not in Il12α-/- mice relative to 
wildtypes.  The p35 subunit of IL-12 (IL-12α) does not transmit signals and is much less 
prevalent than the p40 (IL-12β) subunit (Wang et al., 2004), which may explain why a 
significant effect was observed in the Il12β-/- mice and not the Il12α-/- mice.  In addition, IL-
12p40 forms heterodimers with either p19 or p28 to form the IL-12 family members IL-23 or 
IL-27, respectively (Kobayashi et al., 2003; Owaki et al., 2005).  We therefore cannot 
exclude a possible pathological role for IL-23 and IL-27 for the observed O3-induced 
neutrophilia. 
Our results are consistent with those of Kawakami et. al. (Kawakami et al., 1999) who 
found a marked increase in inflammation when IL-12 was administered to Cryptococcus 
neoformans-infected mice compared to sham-administered controls and also those of Tanaka 
et. al. (Tanaka et al., 1996) who determined that Il12β-/- mice were resistant to liver injury in 
response to LPS compared to wildtype controls.  Ours is the first report that IL-12 contributes 
to O3-induced inflammation.  In contrast, Wang et. al. (Wang et al., 2004) found that the 
absence of IL-12p40 led to marked increases in neutrophilic inflammation compared to 
wildtype mice exposed to respiratory syncytial virus (RSV).  Thus, IL-12 may have different 
functional roles depending on the type or strength of the insult. 
While best known for its synergistic effects with IL-12, IL-18 can act alone on immune 
cells.  Elevated levels of IL-18 have been associated with rheumatoid arthritis, diabetes and 
Crohn’s disease as well as lung diseases including asthma (Nakanishi et al., 2001; Tanaka et 
al., 2001; Wild et al., 2000).  Moreover, IL-18 production has been correlated with TNF-α 
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levels in an endotoxin model (Sakao et al., 1999), and in rheumatoid arthritis patients (Liew, 
2001).  However, no studies have characterized the functional role of IL-18R1 in response to 
environmental exposures.  We determined that IL-18 expression was suppressed in O3-
resistant, Tlr4-deficient C3H/HeJ mice, relative to the C3H/HeOuJ strain.  We found that the 
total number of PMNs was significantly higher in Il18r1-/- compared to Il18r1+/+ mice after 
72 hr O3 exposure.  The protective effect of IL-18 has also been documented in response to 
mycobacterial infection (Mastroeni et al., 1999; Sugawara et al., 1999) and viral infection 
(Fujioka et al., 1999; Sareneva et al., 1998). 
We have previously shown that TNF-α causes O3-induced increases in PMNs (Cho et al., 
2001).  Moreover, IL-18 can induce TNF-α (Jordan et al., 2001).  In the present study, O3-
induced Tnf-α expression was significantly greater in Il18r1-/- compared to Il18r1+/+ mice.  
Our findings are consistent with those of Sakao et. al. (Sakao et al., 1999) who demonstrated 
that Il18-/- mice were highly susceptible to LPS-induced endotoxin shock, and that this 
phenotype was associated with markedly elevated levels of serum TNF-α. 
The mechanism underlying the IL18/TNF-α relationship is not clear.  NF-κB is 
commonly associated with induction of pro-inflammatory genes such as Tnfα.  Moreover, 
IL-18R1 can activate NF-κB via the MyD88 pathway (Nakanishi et al., 2001).  In this study, 
DNA binding of total NF-κB was reduced in the absence of IL-18R at baseline and DNA 
binding of the p65 subunit of NF-κB was reduced in the absence of IL-18R in response to O3.  
These data suggest that O3-induced IL-18R1 signaling is mediated at least partially through 
NF-κB pathways.  However, this finding does not correspond with the observed Tnfα 
expression that was elevated in Il18r1-/- compared to Il18r1+/+ mice.  We propose that NF-κB 
activation and associated TNF-α production in Il18r1-/- mice appear to be independently 
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regulated.  O3-induced TNF-α production may be induced via compensatory upregulation of 
alternative signaling pathways associated with IL-1Receptor or related family members 
(Kleeberger et al., 2000; Park et al., 2004).  Moreover, the discrepancy between O3-induced 
effects of the p65 subunit and total NF-κB binding indicate the p65 may act independently of 
NF-κB in another function. 
The p38 mitogen activated protein (MAP) kinase pathway can result in activated protein 
(AP-1) activation.  In response to LPS, IL-18 activated the MAP kinase pathway to prime 
neutrophils in a concentration-, time-, and calcium-dependent manner (Wyman et al., 2002).  
The present study demonstrated that O3-induced AP-1 activation occurs independently of 
IL18R1, at the concentration and time points tested however.  IL-18R1 mediated MAP 
kinase signaling pathway activation may be dose-dependent and stimulus-specific.  The role 
of IL-18-mediated p38 MAP kinase activation in O3-induced pulmonary inflammation 
upstream of AP-1 remains to be elucidated. 
IL-12 and IL-18 may work synergistically to prevent Th2-driven responses to allergen 
(Hofstra et al., 1998; Lewkowich et al., 2005) and to RSV infection (Wang et al., 2004).  In 
addition, IL-18 selectively induces ICAM-1, and IFN-γ expression and production is 
enhanced by IL-12 (Okamura et al., 1995; Stuyt et al., 2003; Yoshimoto et al., 1998).  It is 
also possible that IL-12 and IL-18R1 interact to control the pulmonary inflammatory 
response to O3, but the exact mechanisms of this interaction remain to be clarified. 
In conclusion, we have shown that the innate immune receptor TLR4 may at least partially 
control expression of IL-12 and IL-18 during the pathogenesis of O3-induced lung injury and 
inflammation.  The p40 subunit of IL-12 (IL-12β) contributes to O3-induced inflammation 
while the IL-18 receptor may play a role in reducing the inflammatory response to O3, 
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possibly through regulation of TNF-α.  These novel observations provide insight into the 
regulatory processes that govern oxidant-induced inflammation and suggest possible links 
between innate and regulatory responses that may prime adaptive immune responses.  
Human polymorphisms in IL12P40 and IL18R1 may help to identify individuals who are 
differentially susceptible to O3 and thus lead to individual-specific treatments. 
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Table 3.1:  cDNA primer sequences and PCR conditions 
Gene Primer Sequences Gene 
Bank ID 
Amplified 
Size (bp) 
Annealing 
Temp (°C) 
PCR 
Cycle No. 
β-actin Forward GTG GGC CGC TCT AGG CAC CA 
Reverse CGG TTG GCC TTA GGG TTC AGG 
11461 221 55 27 
Il18 Forward ACT GTA CAA CCG CAG TAA TAC GG 
Reverse AGT GAA CAT TAC AGA TTT ATC CC 
16173 434 55 30 
Tnfα Forward ATG AGC ACA GAA AGC ATG ATC 
Reverse TAC AGG CTT GTC ACT CGA ATT 
21926 
67 
276 55 30 
Il12 Forward ATC CGA AGC CAG ATT GGT CCA 
Reverse AAC TGA GAT CCA CGA GCG TGA 
16159 782 65 30 
 
Il, Interleukin; TNF, tumor necrosis factor; Temp, temperature 
 
Table 3.2:  Effect of targeted disruption of Il18 on BALF inflammatory cells and total protein after exposure to filtered air or O3. 
Exposure Genotype Total Protein Total Cells Macrophages Lymphocytes Epith. Cells PMNs 
Il18+/+ 65.2 ± 7.9 16,000 ± 1,730 15,500 ± 3,870 54 ± 17 342 ± 39 33 + 13 
Air 
Il18-/- 65.4 ± 6.1 16,800 ± 1,463 16,200 ± 3,191 132 ± 63 364 ± 70 23 + 4 
Il18+/+ 275.2 ± 18.3 23,667 ± 12,004 21,500 ± 3,130 161 ± 15 429 ± 65 1,550 + 139 
0.3 ppm O3, 48 hr 
Il18-/- 237.0 ± 30.3 22,273 ± 6,039 20,900 ± 2,211 113 ± 28 310 ± 37 1,190 + 236 
Il18+/+ 321.8 ± 30.9 28,300 ± 3,537 26,000 ± 9,146 
68
235 ± 141 332 ± 101 1,670 + 208 
0.3 ppm O3, 72 hr 
Il18-/- 315.9 ± 20.4 24,300 ± 4,425 22,400 ± 6,421 79 ± 76 420 ± 136 1,390 + 144 
 
Table represents total protein, total cells, and specific inflammatory cells (macrophages, lymphocytes, epithelial cells, and neutrophils 
(PMNs)) from Il18+/+ and Il18-/- mice in response to air or 0.3 ppm O3. 
 
 Figure 3.1.  Differential mRNA expression of Il12β and Il18 in C3H/HeJ and C3H/HeOuJ 
mice in response to O3. 
 
Differential expression of Il12β (A) and Il18 (B) mRNA after exposure to air and 0.3 ppm O3 
in C3H/HeOuJ and C3H/HeJ mice.  Values are means ± SE (n = 3 per group). * P < 0.05, air 
vs. 0.3ppm O3.  + P < 0.05, C3H/HeOuJ vs. C3H/HeJ. 
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Figure 3.2:  Effect of targeted disruption of Il12 on O3-induced inflammation. 
 
O3-induced inflammation and hyperpermeability responses in Il12α-/- vs. Il12α+/+ mice (A 
and B) and in Il12β+/+ and Il12β-/- mice (C and D) compared to air.  PMN infiltration (A and 
C) and total protein (hyperpermeability) (B and D).  Values are means ± SE (n = 3-6 per 
group).  * P < 0.05 air vs. O3; + P < 0.05, +/+ vs. 
-/-
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Figure 3.3:  Lung histology in Il12β+/+ and Il12β-/- mice in response to air and O3.   
 
Perivascular and peribronchiolar neutrophilic inflammation (arrows) are prominent in O3-
exposed Il12β+/+ compared to Il12β-/- mice.  Terminal bronchiole (TB), Blood vessel (V).  
All images are magnified 32x.  Histology is representative of n = 3 mice per group.  Scale 
represents 200 μm. 
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 Figure 3.4:  Effect of targeted gene disruption of Il18r1 on O3-induced inflammation.  
 
 
Figure represents PMN infiltration (A) and total protein (hyperpermeability) (B) in Il18r1+/+ 
vs. Il18r1-/- mice exposed to air or 0.3 ppm O3.  Values are means ± SE (n = 7 per group for 
PMNs, n = 6-12 for total protein).  * P < 0.05 air vs. O3; + P < 0.05, Il18r1+/+ vs. Il18r1
-/-
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 Figure 3.5:  Lung histology in Il18r1+/+ and Il18r1-/- mice in response to air and O3.   
 
 
Perivascular and peribronchiolar neutrophilic inflammation (arrows) in Il18r1+/+ and Il18r1-/- 
mice in response to 0.3 ppm O3 or air for 72 h.  Inflammatory cells are prominent in O3-
exposed mice and are enhanced in O3-exposed Il8r1-/- compared to Il18r1+/+ mice.  Terminal 
bronchiole (TB), Blood vessel (V).  All images are magnified 32x and are representative of 
histology from individual mice (n = 6 – 12).  Scale represents 200 μm 
 
 73
 Figure 3.6:  Differential Tnf-α expression in Il18r1+/+ and Il18r1-/- mice in response to 0.3 
ppm O3. 
 
Figure represents Tnfα mRNA expression in Il18r1+/+ vs. Il18r1-/- mice in response to air or 
0.3 ppm O3.  Values are means ± SE and have been normalized to 18s (n = 3 per group).  * P 
< 0.05 air vs. O3; + P < 0.05, Il18r1+/+ vs. Il18r1
-/-
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 Figure 3.7:  Differential NF-κB and AP-1 binding in Il18r1+/+ and Il18r1-/- mice in response 
to air and 0.3 ppm O3.   
 
 
Figure represents total NF-κβ binding (A); specific subunit p65 supershift (B), total AP-1 (C) 
of Il18r1+/+ vs. Il18r1-/- mice in response to air or 0.3 ppm O3.  Each lane represents nuclear 
protein pooled from three representative animals of each treatment group and is 
representative of three separate experiments. SB, shifted band; SSB, supershifted band; FP, 
free probe. 
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Running Head: IL-10 and lung O3 toxicity 
 Abstract 
Pulmonary inflammation caused by ozone (O3) is accompanied by increased inflammatory 
mediators including macrophage inflammatory protein (MIP)-2 and co-stimulatory molecules 
such as CD86.  IL-10 is an anti-inflammatory cytokine that is known to inhibit MIP-2 and 
CD86 production.  The current study was designed to test the hypothesis that murine IL-10 
protects lungs from O3-induced inflammation.  Il10-deficient (Il10-/-) and wild type (Il10+/+) 
mice were exposed to 0.3-ppm O3 or filtered air for 24, 48 or 72 hrs.  Immediately following 
exposure, differential cell counts, and total protein (a marker of lung permeability) were 
assessed from bronchoalveolar lavage fluid (BALF).  MIP-2 and CD86 levels were 
determined in lung homogenates.  Transcriptional activation of nuclear factor kappa B (NF-
κΒ) was determined in lung nuclear protein extracts.  Mean numbers of BALF 
polymorphonuclear leukocytes (PMNs) were significantly greater in Il10-/- mice than in 
Il10+/+ mice after exposure to O3.  O3-enhanced production of MIP-2 and CD86 and nuclear 
NF-κB translocation was elevated in the lungs of Il10-/- compared with Il10+/+ mice.  Results 
indicated that IL-10 contributes to protection of O3-induced pulmonary neutrophilic 
inflammation.  These protective effects may be under the control of IL-10-mediated MIP-2 
and CD86 production, and NF-κB activation. 
 
 
 
 
Keywords: IL-10, ozone, lung, inflammation, NF-κB, MIP-2, CD86
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 Introduction 
Ozone (O3) is the most toxic oxidant gas in air pollution mixtures, and has been associated 
with numerous health effects including airway inflammation and hyperreactivity, (Plopper et 
al., 1998; Toward and Broadley, 2002), exacerbation of asthma (McConnell et al., 2002; 
Neuhaus-Steinmetz et al., 2000) and increased mortality and morbidity (Touloumi et al., 
1997).  O3-induced lung inflammation is characterized by polymorphonuclear leukocyte 
(PMN) infiltration (Mudway and Kelly, 2000) and the release of a number of pro-
inflammatory cytokines such as tumor necrosis factor (TNF)-α (Bhalla et al., 2002; Cho et 
al., 2001) and interleukin (IL)-6 (Johnston et al., 2005) and the PMN chemoattractant 
macrophage inflammatory protein (MIP)-2 (Driscoll et al., 1993).  O3 exposure induces 
inducible nitric oxide synthetase (iNOS) (Fakhrzadeh et al., 2002; Inoue et al., 2000; 
Kleeberger et al., 2001) that is thought to contribute to further injury.  Lung injury due to 
either acute or subacute O3 exposure may directly or indirectly affect adaptive immune 
responses such as T-cell proliferation (Jakab et al., 1995), response to allergen (Depuydt et 
al., 2002), and upregulation of co-stimulatory molecules such as CD86 (B7.2) that contribute 
to T-cell activation (Koike et al., 2001). 
IL-10 is a pleiotropic anti-inflammatory cytokine produced by activated monocytes and 
macrophages, helper T cells, and B cells.  Increased IL-10 production decreases TNF-α and 
IL-6 (Lang et al., 2002), and inhibits MIP-2 (Standiford et al., 1995).  Moreover, the 
bioactive IL-10 homodimer exerts anti-inflammatory effects by suppressing macrophage 
CD86 expression on innate immune cells leading to anergic T-cells (Ding et al., 1993; Flores 
Villanueva et al., 1994).  IL-10 also inhibits iNOS production in macrophages (Cunha et al., 
1992) (Tulic et al., 2001), and blocks nuclear factor-kappa B (NF-κΒ) activation  (Saadane et 
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 al., 2005).  Tyrosine phosphorylation of the intracellular domains of the IL-10 receptor is 
known to activate the signaling transducer and activator of transcription (STAT)-3 pathway 
(Donnelly et al., 1999). 
Polymorphisms in IL10 have been identified as a risk factor associated with the 
development of asthma (Chatterjee et al., 2005) and LPS sensitivity (Schippers et al., 2005).  
The functional role of pulmonary IL-10 has been studied in experimental animals in response 
to LPS (Deleuze et al., 2004; Standiford et al., 1995; Tulic et al., 2001), silica (Huaux et al., 
1998), and various parasitic (Netea et al., 2004b) and infectious organisms (Higgins et al., 
2003), and as a key mediator in autoimmune diseases (Gangi et al., 2005), allergy (Akdis et 
al., 2001) and cystic fibrosis (Saadane et al., 2005).  Reinhart et. al. (1999) showed that 
intratracheal instillation of IL-10 significantly attenuated O3-induced BALF albumin, 
fibronectin, and protein (Reinhart et al., 1999).  However, the role of IL-10 in O3-induced 
pulmonary cellular infiltration and its underlying mechanism has not been determined. 
In the current study, we tested the hypothesis that targeted deletion of Il10 in mice 
enhances O3-induced pulmonary inflammation.  O3-induced alterations in pulmonary injury 
phenotypes and putative downstream molecular events were compared between Il10-
sufficient (Il10+/+) and Il10-deficient (Il10-/-) mice.  Differential neutrophilic (PMN) 
infiltration, chemoattractant expression, and nuclear NF-κB activation in the lung indicated 
that IL-10 has a protective role in O3-induced airway inflammation in mice. 
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 Materials and Methods 
Animals.  Male Il10+/+ (C57BL/6) and Il10-/- (B6.129P2-Il10 /J)tm1Cgn  mice (6-8 weeks) 
were purchased from Jackson Laboratories (Bar Harbor, ME).  Gene-targeted knockout mice 
were backcrossed to C57BL/6 mice over ten generations.  All mice were provided water and 
mouse chow (NIH-31) ad libitum.  All experimental procedures were conducted in 
accordance with approved NIEHS Animal Care and Use protocols. 
 
O3 Exposure.  Mice were placed in individual stainless-steel wire cages within a Hazelton 
1000 chamber (Lab Products, Maywood, NJ) equipped with a charcoal and high-efficiency 
particulate air–filtered air supply.  Mice had free access to water and pelleted open-formula 
rodent diet NIH-31 (Zeigler Brothers, Gardners, PA).  Mice were exposed to 0.3-ppm O3 or 
filtered air for 24, 48 or 72 hr (23.5 hr/day).  O3 was generated from ultra-high purity air (< 1 
ppm total hydrocarbons; National Welders, Inc., Raleigh, NC) using a silent arc discharge O3 
generator (Model L-11, Pacific Ozone Technology, Benicia, CA).  The O3 concentration was 
continually monitored (Dasibi model 1008-PC, Dasibi Environmental Corp.).  Parallel 
exposure to filtered air was done in a separate chamber for the same duration.  Constant 
chamber air temperature (72 ± 3° F) and relative humidity (50 ± 15%) were maintained. 
 
Necropsy and Bronchoalveolar Lavage Fluid (BALF) Analysis:  Mice were euthanized 
(sodium pentobarbital, ip., 104 mg/kg) immediately following O3 exposure.  The right lung 
was lavaged with four separate aliquots (26.0 ml/kg, pH 7.2-7.4) of ice-cold Hanks' balanced 
salt solution (HBSS).  The left lung was snap frozen in liquid nitrogen for later molecular 
analyses.  Recovered BALF was centrifuged (500 × g, 4°C, 10 min.).  BALF analysis 
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 followed standard laboratory protocols (Cho et al., 2001).  Briefly, total protein (a marker of 
lung permeability) was determined from BALF supernatants using a Bradford Assay.  Cell 
pellets were resuspended in 1-mL ice-cold HBSS, and total cell numbers were counted with a 
hemacytometer.  A 200 μL aliquot was used to make cytospin slides (300 rpm for 10 min) 
(Shandon Southern Products, Pittsburgh, PA).  Slides were stained with Wright-Giemsa stain 
(Diff-Quik; Baxter Scientific Products, McGaw Park, IL) and differential cell counts (300 
cells/slide) were determined using morphological criteria. 
 
Histological analysis:  Left lungs were inflated with 10% formalin, removed en bloc, and 
immersed in 10% formalin.  After 24 hrs, lungs were cut into three cross sections, and 
processed for microscopic slides.  Hematoxylin and eosin (H&E)-stained tissue sections were 
used to assess the extent of peribronchiolar and perivascular inflammation in Il10-/- and 
Il10+/+ mice qualitatively with the assistance of a pathologist.  Immunostaining for cellular 
proliferation was performed using an anti-Ki67 antibody and slides were qualitatively 
assessed by comparing the extent of Ki67 staining present in peribronchiolar, perivascular, 
and centriacinar areas of inflammation. 
 
Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction (Q-RT-PCR).  
Total RNA was isolated from left lung homogenates using the RNAeasy Midi Kit (Qiagen 
Inc., Valencia, CA) following the manufacturer’s instructions.  One μg of total RNA was 
reverse transcribed into cDNA (50 μl reaction).  The ABI 7000 Sequence Detector (Applied 
Biosystems, Foster City, CA) was used to detect TNF-α and iNOS gene expression using 
qPCR TaqMan ® Gene Expression Power Syber Assays (Applied Biosystems, Foster City, 
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 CA).  Briefly, two μL of cDNA was amplified in a 20-μl reaction containing 10 μL of 2x 
PowerSyber Master Mix (Applied Biosystems, Foster City, CA) and 1 μL of custom specific 
primers for Tnf-α and Nos-2 (Invitrogen, Carlsbad, CA).  18s ribosomal RNA was served as 
an internal control.  PCR was performed by 10 min incubation at 95 oC followed by 40 cycles 
of 95 oC-15 sec and 60oC-1 min. 
 
Western Blot.  Total lung protein was prepared in RIPA buffer containing protease and 
phosphatase inhibitors.  Aliquots of total proteins (30-80 μg) were subjected to Western blot 
analyses with specific primary antibodies for CD86 (SC-19617; Santa Cruz Biotechnologies, 
Santa Cruz, CA), actin (SC-1615, Santa Cruz), phosphorylated STAT-3-tyr 701 (Cell 
Signaling, Danvers, MA), and STAT-3 (Cell Signaling).  Blots were detected using 
SuperSignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL) and BioMaxMR 
x-ray film (Kodak, Rochester, NY).  Intensity of Western blot bands was quantitated using 
the Bio-Rad Gel Doc 2000 System (Hercules, CA). 
 
MIP-2 Protein Enzyme-Linked Immunosorbant Assay (ELISA).  Fifty μL of BALF from 
each mouse was used for ELISA.  The procedures were performed following manufacturer’s 
instructions (R&D Systems, Minneapolis, MN).  All samples were performed in duplicate, 
and absorbances were measured at 450 nm on a Benchmark Microplate Reader (Bio-Rad).  
The minimum detectable dose of murine MIP-2 was less than 1.5 pg/mL. 
Nuclear Protein Isolation and Electrophoretic Mobility Shift Assay (EMSA) for p50 NF-
κB.  Nuclear extracts were prepared from right lung lobes using a Nuclear Extraction Kit 
(Active Motif, Carlsbad, CA).  An aliquot (5 μg) of nuclear protein was incubated in a 
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 binding buffer (10mM Tris, pH 7.5, 50 mM NaCl, 1 mM EDTA, 5 % glycerol, 1 mM DTT, 
0.2 μg PolydI-dC, 1 mM PMSF) in a total volume of 19 μl for 15 min on ice.  The reaction 
was then incubated with 1 μl of [γ32P] dATP end-labeled oligonucleotide containing a NF-κΒ 
consensus sequence (3 x 104 cpm) at room temperature.  After 30 min, the mixture was 
subjected to electrophoresis on a 4 % SDS-PAGE with 0.25X TBE buffer.  The gels were 
autoradiographed at –70 °C.  To analyze specific binding activity of NF-κΒ subunits, nuclear 
proteins (5 μg) were pre-incubated with 4 μg of anti-p50 NF-κΒ antibody (sc-1190X; Santa 
Cruz), and processed for gel shift assay as described above. 
 
Statistics.  All data were expressed as group means ± SE.  The data were transformed, if 
necessary, to ensure normal data distribution and equal variance.  Two-way ANOVA was 
used to evaluate the effects of O3 and IL-10 on pulmonary toxicity.  The factors were 
exposure (air or O3) and genotype (Il10
+/+ or Il10-/-).  The dependent variables were BALF 
protein concentration, BALF PMN numbers, mRNA expressions, and protein levels.  The 
Student Newman Keuls a posteriori test was performed to compare group means.  All 
statistical analysis was performed using a commercial statistics package (SigmaStat, Systat 
Software, Point Richmond, CA).  Statistical significance was accepted at p < 0.05. 
 
Results 
Lung inflammatory responses to O3.  To test the hypothesis that IL-10 contributes to the 
pulmonary inflammatory response to O3, Il10+/+ and Il10-/- mice were exposed continuously 
to filtered air or 0.3 ppm O3 for 24, 48, and 72 hrs.  No significant differences in mean 
numbers of PMNs were detected between Il10+/+ and Il10-/- mice exposed to air.  O3-induced 
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 mean numbers of BALF PMNs were significantly increased in Il10+/+ and Il10-/- mice 
compared to corresponding air controls (Figure 4.1A).  Compared to Il10+/+ mice, mean 
numbers of PMNs were significantly greater (~3-fold) in Il10-/- mice throughout the O3 
exposure.  Total numbers of cells recovered in the BALF were increased in response to O3, 
and were aggravated in Il10-/- compared to Il10+/+ mice.  This difference was attributable to 
differences in total numbers of PMNs and not to other cell types in the BALF (Table 4.1).  
Mean total BALF protein concentrations increased significantly in both genotypes of mice, 
compared to air controls.  However, no significant differences in O3-induced increases in 
BALF protein concentration were found between the two genotypes (p = 0.055) (Figure 
4.1B). 
 
Centriacinar cellular proliferation.  To confirm differential O3-induced inflammation in 
Il10+/+ and Il10-/- mice, H&E-stained lung tissue sections were observed by light microscopy.  
No inflammation was found in air-exposed lungs of Il10-/- and Il10+/+ mice.  O3 caused 
perivascular, peribronchiolar, and terminal bronchial inflammation characterized by 
increased cellularity and neutrophilic infiltration in Il10+/+ and Il10-/- mice (Figure 4.2A).  
O3-induced pulmonary inflammatory infiltrates were more prominent in Il10-/- compared to 
Il10+/+ mice.  The number of Ki67-positive cells at distal perivascular and peribronchiolar 
areas and centriacinar regions increased after O3 in both genotypes.  Ki67-immunostaining 
was visible in Clara cells and alveolar macrophages (Figure 4.2B).  O3-induced Ki67-positive 
cells were more prominent in Il10-/- than in Il10+/+ mice in these focal areas (Figure 4.2B). 
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 Il10-deficiency and O3-induced inflammatory mediator production.  MIP-2 levels were 
determined in BALF as a downstream effector molecule of IL-10 in PMN recruitment.  Lung 
MIP-2 levels increased after O3 compared to air-exposed controls in both genotypes (Figure 
4.3).  O3-induced increases in MIP-2 amounts were significantly higher in Il10-/- compared to 
Il10+/+ mice at 24 hrs (Figure 4.3).  However, these differential levels were not sustained at 
48 and 72 hrs of O3 exposure.  TNF-α and iNOS mRNA expression was significantly 
enhanced by O3 in both genotypes of mice, but no significant genotypic differences were 
determined in the O3-induced message levels of these two inflammatory mediators (data not 
shown). 
 
CD86 production and exposure to O3.  The co-stimulatory molecule, CD86, has been 
shown to increase in alveolar macrophages in response to O3 (Koike et al., 2001) and can be 
inhibited by IL-10 (Ding et al., 1993; Flores Villanueva et al., 1994).  We therefore tested 
whether O3-induced CD86 protein production would be enhanced in Il10-/- compared to 
wildtype mice.  Compared with Il10+/+ mice, significantly higher levels of lung CD86 
proteins were found in Il10-/- mice basally and after O3 (Figure 4.4).  However, O3 exposure 
did not increase CD86 production above basal levels in either Il10+/+ or Il10-/- mice. 
 
Il10-deficiency potentiated O3-induced nuclear NF-κB activity.  NF-κB induces 
transcription of many inflammatory mediators including MIP-2 in response to O3 (Driscoll et 
al., 1993).  Total nuclear DNA binding activity of NF-κB (shifted bands, SB) was greater in 
Il10-/- mice than in Il10+/+ mice basally and after O3 (Figure 4.5A).  Specific p50 κB activity 
was also basally higher in Il10-/- mice than in Il10+/+ mice.  p50 κB activity was enhanced by 
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 O3 in both genotypes, and the induced activity of the specific p50 subunit was higher in Il10-/- 
compared to Il10+/+ mice (Figure 4.5B). 
 
O3-induced effects of Il10 occur independently of STAT-3 activation.  STAT-3 signaling 
pathways have been associated with IL-10-mediated activation (Larner et al., 1993; Tan et 
al., 1993) (Donnelly et al., 1999).  The p-STAT-3/STAT-3 protein ratio increased 
significantly after O3 exposure compared to air controls in both genotypes (Figure 4.6).  
However, no genotype effects were observed in O3-induced increases of p-STAT3/STAT-3 
levels. 
 
Discussion 
The lung is a primary target for exposure to environmental pathogens and is 
immunologically active.  IL-10 is a pleiotropic cytokine that potently suppresses 
inflammation and may direct adaptive immune responses.  The current study investigated the 
role of IL-10 in O3-induced airway neutrophilia in mice and mechanisms leading to its anti-
inflammatory effects.  Targeted deletion of Il10 significantly enhanced O3-induced 
pulmonary cellular inflammation in mice.  O3-induced nuclear activity of NF-κB and 
expression of CD86 proteins were also greater in the lungs of Il10-/- compared to Il10+/+ 
mice.  Our results indicated that IL-10 is essential in modulation of pulmonary inflammation 
caused by O3 in the mouse. 
The anti-inflammatory activity of IL-10 has been noted in a variety of pulmonary models.  
Intratracheal instillation of crystalline silica caused significantly greater increases in levels of 
lactate dehydrogenase, total protein, and numbers of inflammatory cells in Il10-/- than in 
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 Il10+/+ mice, suggesting that IL-10 can limit the amplitude of the inflammatory response 
(Huaux et al., 1998).  In addition, LPS-induced lethality increased significantly when 
endogenous IL-10 bioactivity was neutralized (Standiford et al., 1995).  Similarly, 
intranasally administered recombinant murine IL-10 reduced lung inflammation and 
bronchopulmonary hyperreactivity after airway-instilled LPS administration (Deleuze et al., 
2004).  Patients with cystic fibrosis (CF) and mice lacking the CF transmembrane 
conductance regulator protein (CF-KO) are deficient in IL-10.  In response to LPS, Il10-/- and 
CF-KO mice had more profound neutrophilic inflammation than wildtype counterparts.  
Treatment with exogenous IL-10 in CF-KO mice attenuated excessive LPS-induced 
inflammation and suggests a therapeutic target for increased inflammation associated with 
chronic disease (Saadane et al., 2005).  The immunosuppressive activity of IL-10 has also 
been associated with pulmonary Candida albicans infection (Netea et al., 2004b).  The 
current study demonstrated that IL-10 has anti-inflammatory activity in response to subacute 
exposure to O3.  R.G. Reinhart et. al. (Reinhart et al., 1999) demonstrated that addition of 
recombinant IL-10 significantly attenuated by 25% protein permeability responses induced 
by acute O3 exposure (0.8 ppm, 3 hrs) compared to controls.  This attenuation was attributed 
to decreases in albumin and fibronectin levels.  In the present study, we did not find any 
significant effect of Il10 deletion on protein responses to 0.3 ppm O3.  The role of IL-10 in 
the hyperpermeability response to O3 may be dose-dependent. 
Neutralization of IL-10 prior to LPS administration can attenuate production of the PMN 
chemoattractant MIP-2 and associated neutrophilia (Standiford et al., 1995).  We determined 
that O3-induced increases in MIP-2 levels were potentiated in the absence of Il10 at 24 hrs 
prior to the peak PMN influx.  Upregulation of MIP-2 may increase initial neutrophilic 
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 infiltration while other mediators such as intercellular adhesion molecule (ICAM)-1 may 
control sustained neutrophilia in response to O3 (Takahashi et al., 1995).  In addition to MIP-
2, studies have shown that IL-10 inhibits TNF-α production (Conti et al., 2003) and inducible 
nitric oxide synthase (iNOS) to exert its anti-inflammatory effects (Cunha et al., 1992) (Tulic 
et al., 2001).  Previous work in our lab has demonstrated that TNF-α (Cho et al., 2001) and 
iNOS (Kleeberger et al., 2001) contribute to O3-induced inflammation.  However, we found 
that deficiency in IL-10 did not contribute to O3-induced increases in TNF-α and iNOS 
expression (data not shown).  Others have found similar dissociations between IL-10 and 
TNF-α.  Salez et. al. reported that LPS-induced IL-10 protein and associated TNF-α were 
not detectable in alveolar macrophages while LPS-induced production of these same 
mediators in peritoneal macrophages was robust (Salez et al., 2000).  Deleuze et. al. found 
IL-10-mediated reductions in LPS-induced TNF-α production only when recombinant IL-10 
was administered intranasally and not when generated in vivo after muscle electrotransfer of 
murine IL-10-encoding plasmid (Deleuze et al., 2004).  The relationship between IL-10 and 
TNF-α may be dependent on tissue type and route of administration. 
In addition to controlling inflammatory cytokine expression, IL-10 can inhibit LPS-
induced co-stimulatory molecule CD86 expression on antigen presenting cells (APC) (Ding 
et al., 1993).  Similarly, we found that lung CD86 protein levels were enhanced in Il10-/- 
compared to Il10+/+ mice.  This effect occurred independently of exposure to O3.  Koike et. 
al. found that approximately 8% of alveolar macrophages obtained from rats exposed to 1 
ppm O3 for 3 days were CD86-positive (Koike et al., 2001), and suggested that small 
increases in co-stimulatory activity may be sufficient for regulating O3-induced immune 
responses.  Our results corroborate that of Soltys et. al. who showed that CD86 in alveolar 
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 macrophages was significantly enhanced in Il10-/- mice at baseline (Soltys et al., 2002).  
Soltys et. al. suggested that normally low levels of alveolar macrophage costimulatory 
molecule expression are due to constitutive IL-10 secretion.  Our data similarly indicate that 
Il10-deficiency permits endogenous CD86 expression that would normally be suppressed by 
constitutive levels of IL-10 and could explain why subtle increases in CD86 due to O3 were 
not detectable in Il10-/- mice. 
IL-10 inhibits NF-κB (Saadane et al., 2005; Spight et al., 2005) and mitogen activated 
protein kinase (MAPK) pathways (Haddad et al., 2003; Ward et al., 2005).  We previously 
showed that NF-κB actively binds DNA in response to O3 (Cho, HY, et. al., 2006 Am. J. Crit 
Care Medicine in press).  In accordance with our hypothesis, specific binding of p50 κB 
increased in response to O3 in both genotypes but was enhanced in Il10-/- compared to Il10+/+ 
mice.  Specific binding of p65 was similar (data not shown).  These data are consistent with 
IL-10 mediated protection against O3-induced inflammation through inhibition of the NF-κB 
signaling pathway.  The mechanism through which IL-10 exerts this effect on NF-κB is not 
clear, but may be through inhibition of inhibitory kappa kinase (IκK) as demonstrated in 
response to LPS (Saadane et al., 2005; Spight et al., 2005)or through the action of inhibitory 
p50 homodimers. 
STAT-3 signaling is widely associated with IL-10-mediated activation (Lang et al., 2002; 
Takeda et al., 1999; Williams et al., 2004).  In the lung, STAT-3 has been associated with 
inhibition of IL-10-mediated alveolar macrophage activation by LPS (Berlato et al., 2002).  
This signaling pathway depends on IL-10 receptor ligation to activate Janus-associated 
kinase (JAK) tyrosine kinases that result in phosphorylation and activation of STAT-3 (Riley 
et al., 1999).  There were, however, no significant genotype-specific differences in p-STAT-
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 3/STAT-3 levels, which suggest that STAT-3 activation occurs in an IL-10-independent 
manner in response to O3.  To further isolate the cell types involved with this response, 
immunohistochemical analysis of lung tissue with an IL-10 specific antibody is warranted.  
IL-10-independent STAT-3 activation has been documented, previously.  In response to 
Toxiplasma gondii, IL-10-deficient macrophages did not rescue parasite-induced STAT-3 
phosphorylation, suggesting that STAT-3 phosphorylation occurred independently of IL-10 
(Butcher et al., 2005).  Murray et. al. used a TNF-α-specific targeting vector in Il10-/- mice to 
eliminate the potential confounding effect of TNF-α in IL-10 mediated signaling activation 
and determined that IL-10 primarily acts on STAT-3 indirectly (Murray, 2005).  Other 
STAT-family members such as STAT-1 and STAT-5 could be involved in IL-10 signaling 
activated by O3.  Finbloom suggested that IL-10 may selectively regulate monocytes and T-
cells by differential activation of different STAT proteins (Finbloom and Winestock, 1995).  
IL-10 mediated modulation of NF-κΒ and Iκk activity may also contribute to these effects 
but remains controversial (Spight et al., 2005). 
In conclusion, this study highlights the protective effects of IL-10 on O3-induced 
pulmonary inflammation.  IL-10 deficiency results in enhanced neutrophilic inflammation in 
response to O3 and increased lung injury at the centriacinar region of the lung.  IL-10 has 
multiple immunosuppressive functions that operate to control inflammation.  In response to 
O3, our initial mechanistic work suggests that IL-10’s effect may be mediated at least in part 
by MIP-2, CD86, and NF-κΒ.  Differential response to O3 was independent of activated 
STAT-3 signaling.  Further investigation of the mechanisms through which IL-10 modifies 
responses to O3 will elucidate the pathophysiological regulation of the response to pulmonary 
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 O3 toxicity and may provide a possible therapeutic target for attenuating the effects of O3 in 
susceptible individuals. 
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Table 4.1:  Effect of targeted deletion of Il10 on the inflammatory response to filtered air and 0.3 ppm O3. 
Exposure Genotype Total Cells Macrophages Lymphocytes Epith. Cells 
Il10+/+ 43,833 ± 4,390 42,166 ± 4,191 39 ± 19 1,549 ± 238 
Air 
Il10-/- 39,889 ± 2,815 40,881 ± 4,490 23 ± 11 1,737 ± 171 
Il10+/+ 42,333 ± 5,812 75,956 ± 19,413 24 ±11 4,106 ± 1168
24 h O3
Il10-/- 75,000 ± 4,340 38,829 ± 2,730 0 ± 0 1,718 ± 356 
92 Il10
+/+ 75,000 ± 11,258 75,629 ± 13,039 123 ± 58 3,356 ± 1014
48 h O3
Il10-/- 124,200 ± 33,392 64,108 ± 8,273 1,229 ± 459 2,505 ± 1156
Il10+/+ 80,333 ± 4,807 116,484 ± 23,607 9 ± 4 3,048 ± 923 
72 h O3
Il10-/- 173,400 ± 34,156 128,429 ± 29,561 59 ± 49 1,724 ± 395 
 
Table represents total cells and specific inflammatory cell types (macrophages, lymphocytes, epithelial cells) recovered in the BALF 
from Il10+/+ and Il10-/- mice in response to air or 0.3 ppm O3. 
 
Figure 4.1:  Effect of targeted disruption of Il10 on O3-induced inflammation. 
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Figure represents changes in number of polymorphonuclear leukocytes (PMNs) (A) and total protein concentration (B) recovered in 
the bronchoalveolar lavage fluid (BALF) from Il10+/+ and Il10-/- mice in response to air or 0.3 ppm O3.  Values are means ± SE (n = 
8/group). *, p < 0.05, air vs. 0.3 ppm O3.  +, p < 0.05, Il10+/+ vs. Il10
-/-.
Figure 4.2:  Lung sections from Il10+/+ and Il10-/- mice exposed to air and O3. 
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Lung sections from Il10+/+ and Il10-/- mice in response to air or 0.3 ppm O3 (72 h).  Five micron lung sections were stained with H&E 
(A) and Ki67 immunostaining (B).  (A) Arrows illustrates areas of greatest neutrophilic inflammation, particularly around terminal 
bronchioles (TB) and blood vessels (V). (B) Ki67 immunostaining (Brown dots, arrows) indicate foci of cellular proliferation.  All 
sections are photographed at 20X and are representative of mice from each treatment group.  Bar represents 500 μm for H&E sections 
and 200 μm (B) 
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Figure 4.3:  IL-10-mediated MIP-2 production in response to O3. 
 
MIP-2 protein levels in BALF recovered from Il10+/+ and Il10-/- mice exposed to air and 0.3 
ppm O3.  Values are means ± SE (n = 4 per group).  MIP-2 protein is expressed in pg/mL.  * 
p < 0.05, air vs. O3; + p < 0.05, Il10+/+ vs. Il10
-/-. 
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Figure 4.4:  IL-10 mediated production of CD86 in response to O3. 
 
Lung CD86 protein expression in Il10+/+ and Il10-/- mice exposed to air and 0.3 ppm O3.  
Data are presented as means ± SE (n = 3-5 per group).  CD86 expression was detected from 
whole lung homogenates by Western blot analysis.  Blots were reprobed with actin for 
normalization.  +, p < 0.05. 
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Figure 4.5:  IL-10 mediated DNA binding by NF-κB in response to O3. 
 
Electromobility shift assay to determine DNA binding by total NF-κB (A) and specific 
p50κB (B) in response to 0.3 ppm O3 in Il10+/+ and Il10-/- mice.  Each lane represents nuclear 
protein pooled from three representative animals of each treatment group and was repeated 
three times. S, shift; SSB, Supershifted Band; FP, free probe. 
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Figure 4.6:  STAT-3 activation mediated by IL-10 in response to O3.  
 
 
Phosphorylated-STAT-3 (p-STAT-3) in Il10+/+ and Il10-/- mice in response to air or 0.3 ppm 
O3.  The ratio of p-STAT-3 to total STAT-3 was determined from whole lung homogenates 
by Western blot analysis.  Data are presented as means ± SE (n = 3 per group).  *, p < 0.05, 
air vs. 0.3 ppm O3.
CHAPTER 5: GENERAL DISCUSSION 
 
 Summary  
The descriptive toxicology of ground level O3 has been well characterized, and 
governmental legislation has reduced emissions leading to decreased O3 production 
nationwide.  However, O3 concentrations have not yet reached legislated levels in many areas 
of the U.S. and cause persistent health effects, particularly in susceptible individuals during 
the hot summer months.  In addition, the mechanism(s) underlying O3-induced inflammation 
are still not well understood.  The studies presented here focused specifically on 
understanding the role of innate immune mediators as putative susceptibility genes that may 
alter O3-induced pulmonary inflammation. 
Using linkage analysis, Kleeberger et. al. (2000) identified a significant quantitative trait 
locus (QTL) for susceptibility to O3-induced hyperpermeability in mice (Kleeberger et al., 
2000).  This QTL contains the candidate gene, toll-like receptor 4 (Tlr4).  Proof of concept 
studies in Tlr-mutant and Tlr-sufficient mouse models verified a role for TLR4 in O3-induced 
hyperpermeability responses (Kleeberger et al., 2000). 
We hypothesized that CD14, an accessory molecule to TLR4, as well as proposed 
downstream mediators (IL-12, IL-18, IL-10) would contribute to differential pulmonary 
inflammatory responses to O3.  Commercially available gene targeted knock out mice were 
used to carry out in vivo exposures to O3 under controlled conditions.  Our principal 
phenotypes were neutrophilia and hyperpermeability, derived from cellular analysis of the 
BALF and BALF total protein.  Histological and molecular analysis confirmed our 
inflammatory phenotype and provided insight into the molecular mechanism of action. 
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 Receptor-level events associated with TLR4 
CD14 brings LPS into proximity with TLR4 that then activates intracellular signaling.  
Both genes have been shown to be critical to the response to LPS (Haziot et al., 1994; 
Hollingsworth et al., 2004; Poltorak et al., 1998).  We tested the hypothesis that absence of 
CD14 would diminish O3-induced inflammation.  However, unlike the response to LPS, we 
found that O3-induced inflammation was not different between Cd14+/+ and Cd14-/- mice and 
suggested that neutrophilic and protein permeability responses were independent of CD14 in 
response to O3.  These negative findings are consistent with those of Hollingsworth et. al. 
(2004) who demonstrated that O3-induced hyperreactivity but not inflammation was different 
between Tlr4-deleted and Tlr-normal C57BL/6 mice (Hollingsworth et al., 2004). 
 
The contribution of regulatory cytokines 
O3-induced Il12 and Il18 expression levels were significantly lower in Tlr4-mutant 
compared to Tlr4-normal mice.  Interestingly, Il18 expression was also higher in Tlr4-normal 
compared to Tlr4-mutant mice in response to air.  These results suggested that TLR4 could 
mediate production of regulatory cytokines and provided an initial indicator that TLR4 could 
serve as a link between innate and adaptive immune responses after oxidant injury. 
We then tested the hypothesis that IL-12 and IL-18 would increase the inflammatory 
response to O3.  Neutrophilic inflammation was attenuated in Il12α-/- and Il12β-/-mice 
compared to wildtype controls in response to O3 but only reached statistical significance 
when Il12β-/- were compared to Il12β+/+ mice.  While IL-12 is an important contributor to 
O3-induced inflammation, the IL-12β (p40) subunit is more critical than the IL-12α (p35) 
subunit in modulating this response.  Because p40 is also a component of IL-23 and IL-27, 
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 we cannot eliminate the possibility that these two IL-12 family members may also contribute 
to the underlying pathophysiology of O3-induced inflammation. 
Surprisingly, we found no O3-induced differences in inflammation between Il18+/+ and 
Il18-/- mice suggesting that IL-18 does not contribute to pulmonary inflammation following 
O3 exposure.  IL-18 binds exclusively to the IL-18 receptor, leading us to hypothesize that 
perhaps O3-induced inflammation was IL-18 receptor-dependent.  Interestingly, we found 
that O3-induced neutrophilic inflammation was enhanced in Il18r1-/- mice compared to 
wildtype counterparts suggesting that IL-18 receptor may be protective in the response to O3.  
Further molecular analysis suggested that TNF-α may contribute to this phenotype though 
the mechanism remains unclear.  The discrepancy in O3-induced pulmonary responses 
between Il18-/- and Il18r1-/- mice suggests that IL-18 may not be the sole ligand for IL-18R1.  
Further research is necessary to determine if O3-induced ligands interact with IL-18R1 or if 
the receptor is directly oxidized and structurally altered. 
 
The contribution of anti-inflammatory mediators in controlling inflammation 
Results from our IL-10 studies strongly implicate IL-10 as an important anti-inflammatory 
mediator in O3-induced inflammation.  O3-induced neutrophilic inflammation was 
significantly enhanced in Il10-/- compared to Il10+/+ mice, and these results were confirmed 
by qualitative histological analysis.  MIP-2 levels were significantly enhanced after 24 hr O3 
in Il10-/- compared to Il10+/+ mice.  Molecular analysis showed that IL-10 potently decreased 
costimulatory molecule expression (CD86) and DNA binding of the pro-inflammatory 
transcription factor NF-κB independent of exposure.  Differential response to O3 was not 
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 dependent on STAT-3 signaling.  These results suggested that IL-10 downregulates 
inflammation in response to O3. 
The results of our studies confirm that specific innate immune mediators contribute to O3-
induced inflammation.  Il12 and Il18 expression are at least partially dependent on TLR4.  
IL-12α and, to a greater extent, IL-12β contribute to O3-induced neutrophilia while IL-18R 
and IL-10 are protective.  O3-induced inflammation occurs independently of CD14.  
Subsequent mechanistic analysis is required to more fully understand how these effects 
occur.  Moreover these mediators may have overlapping and/or synergistic contributions that 
require sophisticated experimental designs in order to understand their interactions. 
 
Research Implications and Unanswered Questions 
Implication of CD14 and O3-induced inflammation 
Numerous studies have confirmed that CD14 is required for TLR4-mediated activation in 
response to LPS (Alexis et al., 2001; Haziot et al., 1994; Moreno et al., 2004).  Moreover, 
polymorphisms in CD14 have been associated with differential responsiveness to LPS 
(Baldini et al., 2002) and increased risk for atopy in childhood (Kleeberger and Peden, 2005).  
Clearly, CD14 is important in inflammatory diseases, particularly those that are mediated by 
LPS.  Given our previous finding that TLR4 could mediate the inflammatory response to O3, 
we had strong rationale to hypothesize a putative role for CD14 as well.  However, in 
response to subacute exposures to O3, CD14 did not modulate O3-induced pulmonary injury 
or inflammatory responses in C57BL/6J mice.  Genetic background (C57BL/6) may 
influence the role of TLR4 as well as CD14 in response to oxidant injury.  Further study is 
now required to assess the role of CD14 on a C3H genetic background, the same background 
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 as the C3H/HeJ (Tlr4-mutant) strain that is resistant to the inflammatory response to O3 
compared to C3H/HeOuJ mice (Kleeberger et al., 2000).  It is also possible that CD14 may 
become important only at high doses of O3, albeit at levels that are not environmentally 
relevant. 
 
Interactions between TLR4/IL-10 
Experimental evidence suggests that potential interactions between TLR4 and IL-10 exist 
but were not directly tested in these studies.  For example, Higgins et. al. (2003) found 
reduced IL-10 production in dendritic cells and T-regulatory (T-reg) cells in lungs of 
C3H/HeJ compared to C3H/HeN mice in response to Bordetella pertussis (Higgins et al., 
2003) which may suggest TLR4-initiated control of T-reg cells via IL-10.  DN Cook et. al. 
(2004) (Cook et al., 2004) suggested that people possessing the TLR4 polymorphism D299G 
may have decreased IL-10 production.  TLR4-mediated reductions in IL-10 production may 
explain the link between TLR4 polymorphisms and its effect on asthma and atopic responses.  
In addition, polymorphisms in the proximal IL-10 promoter region were associated with in 
vivo and ex vivo LPS sensitivity, and TLR4 polymorphisms were associated with slightly 
elevated IL-10 production in human cardiology patients (Schippers et al., 2005).  In addition, 
TLR2 signals have been shown to mediate increased IL-10 production in a Candida albicans 
model (Netea et al., 2004b) and in response to Mycobacterium tuberculosis (Jang et al., 
2004). 
In these studies, IL-10 had an anti-inflammatory effect in response to O3, while previous 
studies showed that functional TLR4 contributed to lung injury (Kleeberger et al., 2001).  As 
a central innate immune receptor, TLR4 may limit IL-10 production.  When TLR4 is mutated 
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 or when inflammation reaches a critical threshold, this inhibition is released and IL-10 exerts 
anti-inflammatory effects.  In support of this, Fernandez et. al. (2004) determined that the 
TLR2 ligand, lipoteichoic acid, and the TLR4 ligand, LPS, inhibit the ability of IL-10 to 
induce phosphorylation of STAT-3 in macrophages (Fernandez et al., 2004). 
 
Interactions between TLR4/IL-12p40/IL-10 
A potential interaction may exist among TLR4, IL-10, and IL-12p40.  Though IL-10 and 
IL-12p40 have antagonistic effects, both cytokines are produced in response to LPS and to 
CpG oligonucleotides in the lung (Schwartz et al., 1999) and suggests that TLR4 and TLR2 
are involved in these responses.  Recent studies have provided compelling insights to confirm 
the interdependence among these three mediators.  For example, Zhou et. al. (2004) reported 
that LPS-induced IL-10 inhibited IL-12p40 expression by blocking polymerase II (Zhou et 
al., 2004).  In another study, IL-10-mediated suppression of LPS-induced IL-12p40 
expression was ameliorated in Stat3-mutant macrophages, suggesting that aberrant STAT-3 
signaling prevents the anti-inflammatory effects of IL-10 (Kobayashi et al., 2003).  
Preliminary data showing O3-induced Il12β expression in Il10-/- mice is inconclusive and 
Il10 expression in Il12β-/- mice has not been tested.  Interestingly, a recent paper by Martin et. 
al. (2005) demonstrated that glycogen synthase kinase 3 (GSK3)-β regulated TLR-induced 
inflammatory responses as well as IL-10 and IL-12 production (Martin et al., 2005).  The 
data suggest that GSK3-β may selectively augment anti-inflammatory cytokine production 
while also suppressing pro-inflammatory cytokine production in response to various TLR 
agonists.  This paper provides a novel pathway that may link TLRs, IL-10 and IL-12 while 
providing a potential mechanism for how two antagonistic cytokines could be controlled by 
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 the same innate immune receptor.  The role of polymerase II, STAT-3 and GSK3-β in 
oxidant injury is not known.  We hypothesize that polymerase II is differentially expressed in 
response to O3 vs. air, and that O3-induced inflammatory responses are different in Stat3-/- 
compared to Stat3+/+ mice.  Additionally, we hypothesize that GSK3-β could critically alter 
the pulmonary response to O3 via differential expression of TLR4, IL-10 and IL-12p40.  
Early pro-inflammatory responses to O3 that occur along the pro-inflammatory TLR4-GSK3-
β axis and result in IL-12p40 production would be attenuated by anti-inflammatory Il10 gene 
expression by the same axis. 
However, the relationship between IL-12 and TLR4 became controversial since Merlin et. 
al. (2001) determined that C57BL/10ScCr mice, commonly thought to have an exclusive 
defect in the Tlr4 gene, carry a second genetic defect that leads to IL-12 unresponsiveness 
(Merlin et al., 2001).  IL-12p40 has been shown to be produced in response to numerous 
other infectious and inflammatory stimuli, including Corynebacterium parvum, CpG 
oligodeoxynucleotides, anti-CD40 and low molecular weight hyaluronic acid (Mason et al., 
2002), and suggests that the relationship between IL-12p40 and TLR4 is not exclusive.  
These results imply, with caveats, a plausible relationship among TLRs, IL-10 and IL-12p40 
via novel mechanistic targets including GSK3-β and a rationale for future studies in response 
to oxidant injury. 
 
Interactions between IL-12 and IL-18 
The ability of IL-12 and IL-18 to modify pulmonary immune responses after exposure to 
inflammatory and infectious stimuli is well documented.  For example, IL-12 and IL-18 have 
been shown to prevent Th2-like cellular differentiation in allergic asthma (Akira, 2000; 
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 Hofstra et al., 1998) and to sustain Th1 responses in rheumatoid arthritis (Gracie et al., 1999).  
In addition, IL-12p40 and IL-18 limit lung inflammation and Th2 effector molecules in 
response to respiratory syncytial virus in children and potentially lead to atopy and asthma 
later in life (Wang et al., 2004). 
IL-12 and IL-18 stimulate IFN-γ in response to Chlamydia pneumoniae (Netea et al., 
2004a) as well as LPS and concurrent viral infection (Raue et al., 2004).  IFN-γ potentiates 
the respiratory burst and activity of phagocytes, enhances cellular generation of nitric oxide 
(NO), promotes expression of MHC class I and class II antigens, and induces intercellular 
adhesion molecule (ICAM)-1 expression (Strieter et al., 2002).  In addition, new evidence 
has shown that induction of ICAM-1 was directly enhanced by recombinant IL-12 and IL-18 
in peripheral blood mononuclear cells (Stuyt et al., 2003).  Interestingly, NOS2 production 
and ICAM-1 expression occur in response to O3 (Kleeberger et al., 2001; Mudway and Kelly, 
2000), and provide rationale for IFN-γ and/or ICAM-1 mediated effects directed by IL-12 
and IL-18 in response to O3. 
We showed that TLR4 controlled O3-induced expression of Il12 and Il18.  Conversely, IL-
12 and IL-18 could modify TLR activation since elevated IL-12 and IL-18 levels from the 
synovial tissue of rheumatoid arthritis patients were found to increase expression of TLR4 
and TLR2 (Radstake et al., 2004).  Thus, the immunomodulatory role of TLR4 and IL-12 and 
IL-18 may involve a possible autocrine feedback loop that remains to be fully tested.  
Clearly, IL-12 and IL-18 are important regulatory cytokines that have been implicated in 
inflammatory disease and, at least for IL-12p40, in response to O3.  TLR4-mediated IL-12 
and IL-18 expression may lead to combinatorial effects that influence O3-induced ICAM-1 
and IFN-γ expression.  ICAM-1 is an adhesion molecule that facilitates neutrophilic 
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 migration into the airspaces while IFN-γ stimulates local inflammatory cells.  IL-12 and IL-
18 may then regulate TLR activation to control inflammation. 
We found an inverse functional relationship between IL-12p40 and IL-18 receptor (IL-
18R1) in response to O3.  The relationship between IL-12 and IL-18R1 is not well 
understood.  Coexpression of both IL-18Rα and IL-18Rβ chains are required for IL-18 
binding.  Yoshimoto et. al. (1998) determined that expression of IL-18R1 and significant 
IFN-γ production occurred in splenic T-cells stimulated with IL-12 and IL-18 (Yoshimoto et 
al., 1998).  In support of this, Nakahira et. al. (2001) reported that IL-12 activates STAT-4 
and Stat4-/- mice lack IL-18 binding sites (Nakahira et al., 2001) and suggests that IL-12, 
acting through STAT-4, may control IL-18Rα and IL-18Rβ gene expression (Sergi and 
Penttila, 2004).  However, Nakahira et al. (2001) also demonstrated that upregulation of the 
IL-18Rα chain could occur after IL-12 incubation in resting T-cells, but upregulation of the β 
chain in response to IL-12 stimulation occurred after a significant time delay (eight hrs) 
(Nakahira et al., 2001) that would make it improbable for the IL-18R1 heterodimer to be 
functionally active, at least in response to IL-12.  A strong link between IL-12p40 and IL-
18R1 therefore does not seem to exist. 
 
Interactions between IL-18R1 and other IL-1R superfamily members 
IL-18R1 consists of an α chain, critical for IL-18 binding, and a β chain, for signal 
transduction.  This heterodimeric complex shares structural, intracellular signaling, and 
functional homology with the IL-1 Receptor (IL-1R).  The α and β chains possess 
extracellular immunoglobulin folds and an intracellular signaling domain similar to TLR4, 
which are also members of the IL-1R superfamily (Sergi and Penttila, 2004).  Once IL-18 is 
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 bound to the α subunit and IL-18Rβ is recruited to the complex, IL-1 receptor associated 
kinase (IRAK) and MyD88 are recruited, in the same way as TLR4 and IL-1R signaling.  
Subsequent signaling steps culminate in nuclear NF-κB-dependent induction of pro-
inflammatory gene expression including Il18, Ifn-γ, Tnf-α, and Il1. 
Our studies showed a protective effect of IL-18R1 in response to O3 at 72 hr that is in 
contrast to previous work with other IL-1R superfamily members that demonstrated that 
TLR4 promotes O3-induced hyperpermeability responses (Kleeberger et al., 2001) and that 
an IL-1R antagonist attenuated O3-induced airway hyperresponsiveness as well as TNF-α 
and MIP-2 production (Park et al., 2004).  IL-18R1 may reduce inflammation in the later 
phases of exposure.  There may also be interactive effects where the activity of TLR4 and IL-
1R co-regulate the activation of IL-18R1.  A kinetic analysis of these receptors in response to 
O3 may improve understanding about their role in mediating inflammation during oxidant 
exposure.  A third possibility is that in response to O3, innate immune receptors IL-1R and 
TLR4 have pro-inflammatory effects to generate inflammation and initiate T-cell responses.  
To prevent excessive inflammation, activated T-cells may act via IL-18R1 to decrease 
inflammatory responses. 
 
NF-κB as the inflammatory “master switch” 
Numerous environmental and pathogenic triggers activate multiple receptors including 
TLR4, IL-1R, IL-18R1, and tumor necrosis factor receptors (TNFRs).  Signaling through 
these receptors ultimately result in the release of p50 and p65 from NF-κB’s inhibitory 
subunit, Iκk.  In turn, NF-κB-dependent DNA binding induces production of numerous 
inflammatory cytokines.  Thus, NF-κB is the “master switch” of inflammation.  We have 
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 recently shown that NF-κB actively binds DNA in response to 0.3 ppm O3 (Cho, HY et. al., 
2006, in press). 
Within this group of NF-κB-activating receptors, TNFRs are directly associated with O3-
induced inflammation (Cho et al., 2001) and IL-1R is indirectly implicated via its known 
activation of O3-associated target genes including NO Synthase (NOS2), and ICAM-1 
(Fantuzzi, 2001).  In addition, IL-18R1 and IL-10 modulated specific DNA binding by NF-
κB in these studies and may have regulatory functions.  IL-12p40-mediated differential NF-
κB activation in response to O3 is plausible since Mason et. al. (2002) found that the c-Rel 
subunit of NF-κB was required for IL-12p40 production by a range of infectious and 
inflammatory stimuli (Mason et al., 2002).  Clearly, NF-κB plays a central role in mediating 
responses to oxidant injury and can be influenced by pro- and anti-inflammatory signals.  
The mechanisms through which this occurs are not well understood.  Activation of specific 
inflammatory transcription factors may be one important regulatory factor and remains to be 
tested.  The upstream adaptor molecule, MyD88, may be one link that leads to NF-κB 
activation since targeted disruption of MyD88 results in loss of IL-1 and IL-18-mediated 
functions (Adachi et al., 1998) as well as TLR4 responsiveness.  Receptor clustering by lipid 
rafts, or perhaps a common ligand formed as a secondary oxidation product may determine 
novel and potential antagonistic effects amongst these receptors and mediators to regulate 
NF-κB function.  IL-1R, TLR4, IL-18R1, TNFR, IL-10 and IL-12p40 have complex and 
antagonistic effects on NF-κB activation.  Their multiple interactions, converging at NF-κB, 
modulate the inflammatory response to oxidant injury. 
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 Ozone and the adaptive immune response 
A successful innate defense response in the lung is critical to the transition and 
development of adaptive immune responses (Strieter et al., 2002).  O3 inhalation has been 
shown to affect respiratory tract defense mechanisms, and increased susceptibility to 
infection (Becker et al., 1991), implying that O3 can induce nonspecific and specific immune 
responses. 
Several studies have described O3-induced effects on the innate and adaptive immune 
systems including altered phagocytic activity (Jakab et al., 1995), inability to clear infectious 
disease (Steerenberg et al., 1996), decreased lymphoid organ weights, enhanced T-cell 
proliferation (Jakab et al., 1995), and enhanced response to allergen (Depuydt et al., 2002).  
Several studies have shown a direct effect of CD4+ T-cell depletion on O3-induced 
inflammation (Chen et al., 1995) (Bleavins et al., 1995) while others have shown O3-induced 
effects on B cells (Becker et al., 1991). 
Recent work in our laboratory has identified a role for major histocompatibility complex 
(MHC) II genes in O3-induced inflammatory responses (Bauer, A.K. et. al., in press).  The 
MHC II complex is expressed on antigen presenting cells such as macrophages and dendritic 
cells and permits antigen presentation to T cells and subsequent adaptive immune activation.  
MHC II gene expression occurred only in O3-susceptible B6 mice, compared to resistant C3 
mice.  Moreover, deficiency in MHC class II genes decreased O3-induced neutrophilia, 
implicating these genes in oxidant-mediated pulmonary inflammation.  These genes are 
located within a QTL on chromosome 17 that was previously established as a genetic 
susceptibility locus for O3-induced lung inflammation (Kleeberger et al., 1997).  MHC II 
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 genes thus provide a link between innate and adaptive responses, and further work may 
implicate these genes in modulating T-cell effects. 
We also demonstrated that innate immune genes Il12p40, Il10 and Il18r1 modulate O3-
induced inflammation.  In addition to APCs, IL-18R1 and IL-12R expression levels are 
highest on activated T cells (Gately et al., 1998; Sergi and Penttila, 2004).  The IL-10 
receptor is located on T-cells and macrophages, and has paracrine and autocrine effects on 
both cell types (Akdis et al., 2001).  These genes may directly or indirectly stimulate adaptive 
immune activation. 
We found that O3-induced inflammation was significantly reduced in the absence of IL-
12p40, an IL-12 subunit that also forms part of IL-23.  IL-23 (composed of IL-12p40 and 
p19) has been implicated in the production of a new T cell subset distinct from Th1, called 
Th-IL-17 (Langrish et al., 2004) produced by memory T-cells (Kolls and Linden, 2004).  IL-
23 can also lead to enhanced antigen presentation and IFN-γ production that can alter T-cell 
activities (Langrish et al., 2004).  These findings suggest that IL-23 may prime the adaptive 
immune response for allergic responsiveness via IL-17-producing memory T-cells but 
remains to be tested experimentally in response to O3. 
In response to Chlamydia pneumoniae, IL-12 and IL-18 stimulate IFN-γ production 
(Netea et al., 2004a) and potentially activate immune responses without antigen receptor 
engagement (Nakanishi et al., 2001).  Thus T-cell stimulation can occur without physical 
contact with activated innate immune cells.  In addition, IL-12 and IL-18 have been shown to 
prevent Th2-like cellular differentiation in allergic asthma (Akira, 2000; Hofstra et al., 1998), 
to sustain Th1 responses in rheumatoid arthritis (Gracie et al., 1999), and activate CD8+ T-
cells in response to LPS (Raue et al., 2004).  In children with respiratory syncytial virus, IL-
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 12p40 and IL-18 limit Th2 effector molecules and potentially lead to atopy and asthma later 
in life (Wang et al., 2004).  This evidence provides rationale for further investigation into 
whether IL-12 and IL-18 contribute to adaptive immune activation in response to oxidant 
injury. 
Of the cytokines we investigated, IL-10 is the most pleiotropic.  IL10 polymorphisms are 
associated with asthma phenotypes in children and indicate a role for adaptive immune 
responses (Lyon et al., 2004).  IL-10 suppresses CD86 costimulatory molecule expression on 
APCs (Soltys et al., 2002), a critical signal for adaptive immune activation.  Moreover, IL-10 
directly blocks the CD28 co-stimulatory signal in T cells in allergic inflammation (Akdis et 
al., 2001).  CD4+CD25+ regulatory T-cells secrete IL-10 to suppress immunity against 
Candida albicans (Netea et al., 2004b), Bordetella pertussis (Higgins et al., 2003), and 
autoimmune thyroiditis (Gangi et al., 2005).  B-cells, dendritic cells, and other T-cells also 
produce IL-10 and multiple cell types from both innate and adaptive immune cells can induce 
a “stop” signal at high levels of inflammation via production of this cytokine (O'Garra et al., 
2004).  Koike et. al. (2001) reported that expression of CD86, (a costimulatory molecule on 
APCs) was enhanced in response to O3 (Koike et al., 2001).  We showed that CD86 was also 
enhanced in Il10-/- compared to Il10+/+ mice.  These findings indirectly suggest that T-cells, 
responding to CD86, may be primed in response to O3 and may be under the control of IL-
10.  To further elucidate O3-induced adaptive immune effects mediated by IL-10 and other 
mediators, we must investigate T-cell specific endpoints such as differential T-cell activation, 
CD28 expression, and T-cell activity. 
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 Future Directions  
IL-23 and IL-27 may contribute to O3-induced inflammation 
In assessing the role of the heterodimeric cytokine IL-12, we determined that one subunit, 
IL-12p40, contributes to O3-induced inflammation.  IL-12p40 also forms part of the newly 
characterized cytokines IL-23 and IL-27 (Hunter, 2005).  The possible pathological roles of 
these two cytokines in oxidant-mediated lung injury have not been determined. 
IL-12 and IL-23 are cytokines produced by activated macrophages within hours of 
stimulation.  An IL-12p40-dependent but IL-12p70-independent mechanism controls 
mycobacterial and Francisella tularensis infections, suggesting novel and unique roles for 
the p40 subunit (Langrish et al., 2004).  IL-12p40 has been implicated in pulmonary 
responses to Mycobacterium tuberculosis (Cooper et al., 2002) and was later specifically 
associated with IL-23 (Happel et al., 2005).  Also TLR4 is required for induction of p19 
subunit of IL-23 in response to Klebsiella pneumoniae (Happel et al., 2003).  In a model of 
enterocolitis, TLR4-mediated recognition of microbial components triggered IL-12p40 
production in Stat3-deficient mice (Kobayashi et al., 2003).  The potential connection 
between TLR4 and IL-12p40/IL-23 cytokine production provides further rationale to 
determine whether IL-23 is differentially expressed in Tlr4-normal vs. Tlr4-mutant mice and, 
in turn, whether there is a possible pathological role for IL-23 in oxidant-mediated lung 
injury. 
IL-27 limits the intensity and duration of adaptive immune responses (Hunter, 2005) and 
induces rapid ICAM-1 expression on naïve CD4+ T-cells, leading to Th1 differentiation 
(Owaki et al., 2005).  O3-induced IL-27 production has not been tested in differentially 
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 susceptible mouse strains.  Based on its functionality, IL-27 may best be assessed at later 
timepoints using T-cell based assays. 
 
Ozone-allergen studies: 
Asthma is a chronic, inflammatory disorder with a complex etiology consisting of both 
polygenic and environmental factors (Backus-Hazzard et al., 2004).  Asthma symptoms 
include wheeze, airway hyperresponsiveness, pulmonary inflammation, and mucus 
hypersecretion.  Atopic asthmatics comprise approximately 75% of asthmatic patients and 
have a Th2 immunological profile that includes airway eosinophilia, IgE production, and 
increases in IL-4, IL-5, and IL-13 (Umetsu et al., 2002).  Epidemiological and experimental 
evidence suggest that air pollutants such as O3 exacerbate asthmatic symptoms and may 
contribute to increased asthma prevalence (Kunzli et al., 2003; McConnell et al., 2002; 
Vagaggini et al., 2002).  O3 may have a priming effect on allergen-induced responses and 
intrinsic inflammatory action in nasal airways of asthmatics (Peden et al., 1995).  Further 
mechanistic work is needed to fully characterize the pathophysiology of O3-induced 
inflammation in allergic and asthmatic animal models (Kleeberger and Peden, 2005). 
The present studies have identified IL-10 and IL-12p40 as new cytokine targets that 
critically regulate O3-induced inflammation.  Polymorphisms in IL10 have been associated 
with allergic asthma in a North Indian family-based study (Chatterjee et al., 2005).  In a 
separate study, polymorphisms in IL10 (3’ Untranslated region (UTR)) were associated with 
asthma-specific phenotypes such as FEV1, percent predicted (measured FEV1 as a percent of 
predicted FEV1) and IgE levels (Lyon et al., 2004).  Polymorphisms in IL12B have been 
associated with childhood asthma in a Japanese population (Hirota et al., 2005), adult asthma 
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 in a white population (Randolph et al., 2004), and may be linked to asthma severity rather 
than susceptibility (Morahan et al., 2002).  Thus, IL-10, IL-12p40 can critically affect 
adaptive responses.  Moreover, there is a potential interaction between these two cytokines 
and atopic asthma.  In addition, our current findings suggest that these cytokines importantly 
contribute to O3-induced inflammation.  For these reasons, we hypothesize that IL-10 and/or 
IL-12p40 contribute to O3-induced exacerbation of allergic responsiveness. 
 
Gene Array studies 
The complex pathophysiology of O3-induced inflammation is modified by a number of 
interactive genes of which only a few were tested in these studies.  Of particular interest was 
the finding that O3-induced neutrophilic inflammation was significantly enhanced in Il10-/- 
mice over that produced by an already susceptible mouse strain, the C57BL/6.  Further 
analysis revealed that IL-10 affected a number of important downstream factors including 
NF-κB, MIP-2, and CD86.  These findings were among the first to implicate an anti-
inflammatory cytokine as critical to the response to O3.  To further characterize the complex 
phenotype elicited by IL-10, RNA was isolated from lung homogenates of Il10+/+ and Il10-/- 
mice after exposure to air or O3 and was hybridized to Affymetrix Gene Array chips 
containing all known mouse genes.  This gene array currently awaits analysis and will 
hopefully provide insightful information as to related genes that interact with IL-10 and 
provide new targets for functional confirmation. 
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 Human Implications 
These projects focused on specific innate immunity genes Cd14, Il18r1, Il12p40 and Il10 
and their contribution to the response to O3 in mice.  Ultimately, these results must be 
extrapolated to humans to establish clinical relevance as susceptibility genes.  Human 
variants in these genes exist and are functionally important in inflammation and atopic 
phenotypes.  For example, the CD14-C159 T single nucleotide promoter polymorphism 
represents a well-studied example of a genetic influence on diseases associated with 
inflammation (atopy) (Baldini et al., 2002; Kleeberger and Peden, 2005; Vercelli, 2002).  In 
humans, different polymorphisms in the promoter region of IL10 have been identified as risk 
and protective factors associated with the development of asthma (Chatterjee et al., 2005).  
Other IL10 promoter polymorphisms are associated with increased LPS sensitivity 
(Schippers et al., 2005).  Similarly, polymorphisms in IL12B have been linked with hepatitis 
C virus infectivity (Houldsworth et al., 2005), and atopic asthma (Hirota et al., 2005; 
Morahan et al., 2002; Randolph et al., 2004).  Thus, each of these cytokines has 
polymorphisms that have been implicated in inflammatory diseases, and CD14, IL10 and 
IL12B have specifically been linked to asthma.  In addition, IL18R1 promoter polymorphisms 
have recently been identified (Cardoso et al., 2004) but functional relevance to human 
disease has not yet been established (Table 5.1).  The relationship between human 
polymorphisms in CD14, IL10, IL12B, and IL18R1 and O3 susceptibility has not been 
established.  If associations are found, they could provide new insights into potential genetic 
markers of susceptibility and novel therapeutic targets.  Moreover, polymorphisms in these 
genes, if associated with O3 susceptibility, could also provide insight into the genetic 
contribution to O3-induced exacerbation of asthma.  However, individual single nucleotide 
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 polymorphisms may be insufficient by themselves to cause disease, but combinations of 
variations in the same gene or in gene-gene interactions may eventually generate enough 
“hits” to generate dysfunction (Vercelli, 2002). 
 
 118
 Limitations 
Inflammation is a highly complex process 
The innate immune defense system consists of numerous layers that are regionally 
distinct.  In the upper airways, the mucociliary escalator and epithelial barrier of the upper 
respiratory tract form primary defense barriers while innate immune cells such as 
macrophages, natural killer cells, mast cells, and dendritic cells as well as secreted mediators 
monitor the lower airways.  All of these components are organized to sequester the invading 
pathogens, neutralize them and then repair the lesion or remodel the tissue.  If these 
processes are not properly regulated, excessive tissue inflammation can lead to irreversible 
tissue damage (such as fibrosis) (Strieter et al., 2002).  The present studies focused on airway 
inflammation mediated largely by macrophages.  Specific cell types in the lower and upper 
airways were simultaneously affected by O3 and contributed to an overall inflammatory 
phenotype. 
Cytokines such as IL-12, IL-18, and IL-10 are instrumental in orchestrating inflammation 
and have been shown to be critical in modulating the pulmonary response to O3 in particular.  
However, these cytokines do not act in isolation but rather in combination with a number of 
other factors including arachidonic acid metabolism, coagulation factors, complement, acute 
phase proteins, and antimicrobial peptides.  The present studies did not incorporate 
consideration of the complex interaction between cell types, cytokines and other 
inflammatory mediators. 
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 Genetic background 
To study the genetic contribution underlying O3-induced pulmonary inflammation, we 
utilized commercially available gene targeted knock out mice in a candidate gene approach.  
The advantages of using a mouse model include availability, quick generation time, genetic 
similarity between individuals, large numbers of progeny from controlled crosses, and the 
possibility of studying contributions from whole or segments of chromosomes using 
congenic and consomic strains. 
However, genetic background contributes substantially to differential responses to 
exposure.  In response to 0.3 ppm O3, neutrophils were significantly elevated in C57BL/6 
compared to C3H/HeJ mice (Kleeberger et al., 1993a).  Other mouse strains respond to O3 
along a continuum from resistant to susceptible.  To control for this potential confounding 
factor, all gene targeted knock-out strains used in our studies were generated on a similar, 
mixed C57BL/6 – 129 (B6.129) background (e.g. Il12α-/-. Il12β-/-, Il18-/-, Il18r1-/-, Il10-/-).  
Mice generated as B6.129 hybrid strains were repeatedly backcrossed to C57BL/6 mice for at 
least 10 generations (Il18r1-/-: 10 generations, Il18-/-: 10 generations, Il12β-/-: 11 generations, 
Il12a-/-: 11 generations, Il10-/-: 10 generations) and are thus comparable to the C57BL/6 
strain, used as a wildtype control.  However, we cannot rule out the possibility that the 129 
background may slightly influence the response in these strains.  Moreover, the C57BL/6 
strain is a high TNF-α responder and a high IL-10 responder (De Maio et al., 2005) and has a 
predisposition toward a Th1 cytokine profile.  This basal profile influences the way these 
mice respond to O3. 
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 Gene-Environment interactions are complex 
The etiology of complex lung diseases is difficult to determine because of the interaction 
between multiple genetic and environmental factors (Kleeberger and Peden, 2005).  
Moreover, an individual single nucleotide polymorphism (SNP) may be insufficient to cause 
disease but might become significant when combined with other SNPs or specific 
environmental exposures (Vercelli, 2002).  Multiple genes (each with modest effects) operate 
to modify pulmonary inflammatory responses to O3 and, in addition, these multiple genes 
interact with multiple environmental factors that contribute to disease pathogenesis 
(Kleeberger and Peden, 2005).  The candidate gene approach used in these studies is an 
important tool for gaining insight into the genetic pathways that mediate pulmonary 
inflammation and can provide the information necessary to understand at a molecular level 
how these variants contribute to differential phenotypes (De Maio et al., 2005).  However, 
the single gene approach does not permit investigation of the complex interplay of genetic 
and environmental factors that truly drive these responses.  To address these concerns, the 
candidate gene approach can be used in a gene array to witness gene-gene interactions in 
response to single or relevant combinations of environmental exposure(s). 
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 Conclusion 
The negative effects of air pollution have received public attention in the U.S. since the 
early 20th century.  O3 damages lung tissue, aggravates lung disease, and increases 
susceptibility to respiratory infections particularly in children, the elderly and individuals 
with preexisting disease, such as atopic asthma (Mudway and Kelly, 2000).  O3-induced 
pulmonary inflammation is a tightly orchestrated process involving antioxidants as well as 
numerous cell types and gene products (De Maio et al., 2005).  This project focused on the 
individual contribution of several important regulatory and anti-inflammatory cytokines, as 
well as a protein associated with the important innate immune receptor, TLR4, in response to 
the environmental pulmonary toxicant, O3.  These studies showed that O3-induced 
inflammation is probably mechanistically distinct from other insults (such as LPS and RSV).  
In viewing the lung as immunologically active, this dissertation showed that innate immune 
response genes contribute to differential susceptibility to O3-induced neutrophilic 
inflammation, and provided new targets for further research.  In particular, these studies are 
the first to determine that an anti-inflammatory cytokine, IL-10, can attenuate O3-induced 
inflammation.  In addition, data presented here provided indirect evidence that IL-12p40 and 
IL-10, cytokines that have paracrine effects on adaptive immune cells, may modulate 
adaptive immune responses.  These candidate genes should be tested in an O3-allergen model 
to assess their putative role as susceptibility genes underlying O3-induced exacerbation of 
allergic responsiveness.  Overall, this dissertation contributed to an increased understanding 
of the complex gene(s)-environment interactions involved in pulmonary oxidant injury. 
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 Table 5.1:  Human polymorphisms in innate immune genes and disease associations 
Gene Polymorphism Disease Association Reference 
House dust endotoxin Zambelli-Weiner, A et. al., 2005 -260: C/T 
Myocardial infarction Hubacek, AJ et. al., 1999 
Cardiovascular mortality 
in dialysis pts Losito, A et. al., 2005 
Baldini M et. al., 2002 
CD14 
-159: C/T  
Risk of atopy Kleeberger, SR and 
Peden, DB., 2005 
Polymorphism in the 3’ 
UTR Autoimmune diabetes Adorini L., 2001  
3’ UTR, +1188: A/C Hepatitis C infectivity Houldsworth, A et. al., 2005 
3” UTR, 10841: C/A Hirota, T. et. al., 2005 
3’ UTR +1188 A/C  Morahan, G. et. al., 2002 
IL12B 
+4237: G/A 
Atopic asthma 
Randolph, AG et. al., 
2004 
IL12A +8685: G/A Occupational benzene exposure Lan, Q et. al., 2005 
+105: G/C Asthma Higa, S et. al., 2003 
-607: A/C Allergic rhinitis Lee, HM et. al., 2006 
+113: G/C, +127: G/C, -
137: G/C, 
-33: G/C 
Atopic eczema Novak, N et. al., 2005 IL18 
-148: G/C, +13925:A/C Mite allergen Shin, HD et. al.,  2005 
IL18R1 -69: C/T -638: C/T  N/A Cardoso, SP et. al., 2004
Promoter, IL10 R/G 
haplotype LPS sensitivity Eskdale, J et. al., 1998 
IL10.R microsatellite Rheumatoid arthritis Eskdale, J et. al. 1998 
-592: *A or *C SIDS Summers, AM et. al., 2000 
IL10 
-2849: A/G Rheumatoid arthritis Lard, LR et. al., 2003 
 
Known polymorphisms in human innate immune genes (CD14, IL12A, IL12B, IL18, IL18R1, 
and IL10) are associated with numerous inflammatory diseases including atopy, allergy, and 
asthma. 
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